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Metabolomics is a powerful science that can be applied for the discovery of disease
biomarkers, and investigation of altered metabolomes due to abiotic and biotic perturbations. This
dissertation is focused on untargeted metabolomic applications to investigate fungal metabolite
alterations associated with pathogenicity, fungal disease propagations, and symbiosis.
This dissertation employs qualitative analysis of metabolite mixtures using HS-SPME
coupled GC-MS and TMS derivatization followed by GC-MS analytical platforms. In the first
study, we discovered a biomarker combination to diagnose fungal soft tissue disease in sweet
potato at an early stage of disease propagation. We used an HS-SPME GC-MS untargeted
metabolomics workflow to analyze the VOC associated with Rhizopus stolonifer infected and
healthy sweet potatoes in situ and simulated warehouse environments. A single combination of 4
biomarkers was able to diagnose R. stolonifer fungal soft tissue disease (AUC = 0.980, 95% C.I.
0.937-1) and the early stage of the fungal soft rot disease (AUC = 0.999, 95% C.I. 0.978-1). We
were able to detect the biomarkers: 1- propanol, ethyl alcohol, ethyl propionate and 3-methyl-3buten-1-ol during disease progression in a simulated warehouse environment. Therefore, this study

shows the feasibility of early diagnosis of fungal soft tissue disease by a real-time screening of
volatile profiles of sweet potato in post-harvest storage.
When considering the study of a particular species metabolome, it is crucial to develop a
metabolite extraction protocol. In the second study, the performance of the six different metabolite
extraction solvents mixtures was tested with the preferred mix being: butanol:methanol:water
(2:1:1, v/v at -20 °C) which was used as a single solvent mix to extract both polar and relatively
non-polar metabolites simultaneously in a single extraction step. The Macrophomina phaseolina
fungal metabolome was investigated using the solvent mix.
Finally, fungal mutualism was studied using untargeted metabolomics. Most often
mycorrhizal metabolomics workflows are based on analyzing the Arbuscular Mycorrhizae
colonized root metabolome. But here, we used hyphal materials to examine the mutualistic
symbiotic association of the AM fungi. All untargeted metabolomic studies included chemometric
data analysis and specific biomarkers and or metabolites were determined using multivariate
statistics or prediction model building and validating.
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CHAPTER I
INTRODUCTION TO UNTARGETED METABOLOMICS FOR FUNGAL METABOLITES
USING HYPHENATED MASS SPECTROMETRY
1.1

Introduction
Metabolomics is the analytical science of metabolites or all low molecular weight

molecules (< 1500 Da) in biological and non-biological systems.1,2 This group of compounds is
known as the metabolome, and it dictates the response to both processes necessary to maintain
homeostasis and responses to a/biotic stress.
Metabolomics differs from other “omic” sciences such as proteomics, lipidomics, and
genomics that create a catalog of specific molecules within the biological body. Proteomics or
genomics may not provide enough information to fully understand the phenotype or the cellular
functioning of a living being.3 The metabolome is comprised of compounds that represent the endstage of the genome or protein expression4, and this allows a researcher to create a comprehensive
catalog of the molecules within a specific metabolic pathway. However, metabolomics may
become broadly applied, allowing a researcher to understand what is happening inside an
organism.

Metabolomics is an emergent field of study that is especially relevant because

biomarkers—detectable diagnostic compounds produced with all biological processes —can be
assessed for all living creatures: from humans to fungi.

1

Figure 1.1

Schematic illustration for general metabolomics workflow

Study design, metabolite extraction, chromatographic separation and or the metabolite detection,
spectral pre and post-processing, chemometric data analysis, and biological interpretation of the
significant metabolites are the main steps involve with the metabolomics workflow.
1.2

Untargeted metabolomics
In general, there are two classes of metabolomic studies, untargeted and targeted.

Untargeted metabolomics is a comprehensive or qualitative study, and many of the detected
compounds can be associated with biological processes (Figure 1.1).5,6 In some cases, untargeted
metabolomics can be quantitative, but those cases are very rare. With this approach, all the detected
chemicals in the sample are used in analysis even if they are near the limits of detection and not
consistently present. The interpretation of this data is more challenging, and often requires
chemometric analysis (details in section 1.7.2.2 under the multivariate analysis). Untargeted
metabolomics is often applied when the biological pathway affected by a pathogen or
environmental stimuli is unknown. By assessing all detectable metabolites, or any specific
compounds (biomarker discovery, etc.) related to the biological perturbation, the altered
2

metabolome will be identified with untargeted metabolomics approaches. Typically, data or
findings are presented qualitatively rather than quantitatively; however, in some instances,
quantitative or semi-quantitative results are recorded using internal standards or external
calibration curves.7,8 Therefore, untargeted metabolomics is highly applied in biomarker
discovery, assessing novel pathways for host-pathogen interaction, etc.
The goal of the untargeted metabolomics is to identify all detected compounds (Figure 1.2).
Therefore, in untargeted metabolomics is very important to understand phenotype variation by
interpreting altered metabolite profiles from different phenotypic groups. Furthermore, these
metabolites may or may not be subjected to prior research. Therefore, untargeted metabolomics is
vital for new metabolite discovery in specific biological pathways.

Figure 1.2

Annotated TIC of GC-MS analysis of a volatile metabolite mixture

In untargeted metabolomics, every detected metabolite/peak is essential for the diagnosis of the
perturbation of the biological system.
3

1.3

Targeted metabolomics
Targeted metabolomics is carried out with some prior knowledge of the metabolites or

known pathways involved in cell biology. Targeted metabolomics seek to characterize the function
of a specific pathway by measuring metabolites, which can qualify the metabolites presence in the
process.9 Therefore, one standard method of targeted metabolomics involves introducing a labelled
isotope into the system. As the labelled isotope travels along the metabolic pathway, it can be
quantitatively assessed.10 This specific compound approach contrasts with untargeted
metabolomics, which casts a wide net and evaluates all captured metabolites. Often, metabolites
are quantitively assessed (Figure 1.3) using an isotopically labelled internal standard/s (stable
isotopes), but there can be limitations due to the availability of the isotopically labelled compounds
of the interest. Targeted metabolomics are highly applied in drug discovery and disease monitoring
using pre-identified biomarkers.11–13

4

Figure 1.3

1.4

Targeted metabolomics for target analyte: A targeted metabolomics analysis of
“A” using GC-MS EI SIM (Gas Chromatography Mass Spectrometry Electron
Impact Selected Ion Monitoring). The RT (retention time) and mass spectrum of
“A” are determined first using full scan mode, and then the SIM mode is applied.
“A” is quantified using a standard calibration curve.

Analytical methods in metabolomics
Metabolomics data can be acquired from various analytical platforms such as nuclear

magnetic resonance (NMR) spectroscopy, gas or liquid chromatography coupled to mass
spectrometry (GC-MS, LC-MS), capillary electrophoresis (CE-MS).14,15 Each analytical platform
has pros and cons that are unique for each. NMR is a non-destructive detection method that needs
minimal sample preparation compared to the MS platforms, but NMR has high detection limits.
Contrary to NMR, MS has detection capabilities in the pico/femto gram range depending on the
mass analyzers being used.16 MS-related platforms have higher throughput and metabolite
coverage compared to NMR. The analysis in metabolomics is a challenging analytical endeavor
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due to the broad swath of chemical classes needed to be detected. NMR and mass spectrometry
are the most commonly used analytical platforms in metabolites analysis. It should be noted that
no single analytical platforms can identify and quantify the entire metabolome of a single species.
A combination analytical platforms or modification of metabolomics workflows should be used to
enhance metabolome coverage. Although NMR and hyphenated mass spectrometry are intensively
used in metabolomics workflows, realizing the pros and cons of each method can help with the
choice of technique used to elucidate a specific targeted metabolome.
1.4.1

Gas chromatography-mass spectrometry (GC-MS)-based metabolomics
GC-MS is the oldest method of coupling chromatographic technique with mass

spectrometry.16 GC-MS has been widely used in both targeted and non-targeted metabolomic
applications.17–19 Collected samples are introduced in splitless or split modes (sometimes in
derivatized metabolites analysis) where they are vaporized at ~250-300 °C in the injector. These
gaseous molecules are then separated into individual components as they travel through the
temperature-controlled column. An inert gas (commonly ultra-high pure helium or nitrogen)
flowing through the column carries the analytes, and analytes are separated based on physical
(boiling points or relative vapor pressure) or chemical (equilibrium of the solid and gas phase)
properties. Analyte properties required for GC-MS analysis are discussed in detail in section 1.5.2.
GC-MS commonly uses electron impact (EI) ionization as the mode of ionization. EI is a
hard ionization technique because it uses high-energy electrons (70 eV) to ionize molecules, which
fragments the molecule making it difficult to find the molecular ion or parent ion in the spectrum.
Another disadvantage of GC-MS-EI is the limited mass range (50-550 m/z).20 However, despite
this disadvantage compared to the other soft ionization methods (discussed below), EI is often
utilized because this technique is highly reproducible.20
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Soft ionization techniques are also use in GC-MS, such as CI (chemical ionization).21 CI
can be used as positive (PCI) or negative ionization (NCI). In CI, a reagent gas (commonly
methane, ammonia, water, and isobutane) is use for proton transfer to the analytes (PCI) or electron
transfer to the reagent gas (NCI).22 CI is preferentially used in targeted metabolomics because the
reagent gas can be selected based on the targeted analyte.21 Figure 1.4 illustrates the EI and CI
process.

Figure 1.4

Popular ionization techniques used in GC-MS A: EI ionization produces more
fragmentation B: Chemical ionization uses a reagent gas (R) and produces more
parent peaks.

Single quadrupole (Q) mass analyzers are widely used in GC-MS instruments; however,
some studies use HRMS21 (high-resolution mass spectrometry). Time-of-flight (TOF)23, (Q or
3Q)18,24, and hybrids of these mass analyzers (e.g.: Q-TOF)25 can be used in metabolomics studies.
Targeted metabolomics uses MS/MS more often than single MS analysis for the purpose of analyte
identification and quantification by using the SIM (selected ion monitoring). All GC-MS-related
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studies reported in this thesis use EI as the ionization technique with a single quadrupole mass
spectrometer.
1.5
1.5.1

Method development in metabolite extractions
Volatile metabolite extraction
Volatiles released from biological systems can be captured using several techniques, such

as solvent extraction, cold trapping, distillation, however, solid-phase extraction is considered to
be superior.26 Liquid extraction is a destructive sampling method. Biochemical reactions can be
altered due to stresses added by the sampling method; therefore, low stress sampling methods are
preferred for best understanding the real-time chemistry of a living being. After considering all
the above factors, in-situ capturing of volatile compounds is the most reliable method to get a
snapshot of a particular biological system.27 The second chapter of this thesis monitors soft tissue
disease propagation in potatoes. In that case, we needed a method to capture real-time volatiles
released from the infected sweet potatoes to understand the disease propagation. Solid-phase
microextraction (SPME) of the headspace was chosen as the suitable method for the in-vivo
assessment of volatile metabolites. SPME can be used in 3 ways: static, dynamic, and direct
contact sampling,28,29 as illustrated in Figure 1.5.
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Figure 1.5

Three different solid phase extraction methods for volatile organic compounds
trapping.

Figure 1.5 demonstrates that dynamic SPME uses an inert gas flow to flush the volatiles
which are then adsorb into the adsorbent. Some sophisticated equipment is required, and the
desorption of the volatiles is often carried out using solvent extraction. The direct SPME method
makes direct contact with the plant material or the biological system. The static SPME technique
is used in chapter 2 of this thesis to capture real-time disease biomarkers using an e-nose sensor in
a warehouse environment. The equilibrium between the biological system and the headspace and
the equilibrium between the headspace and the SPME fiber affect the metabolite’s adsorbance to
the SPME fiber coating.
SPME adsorbent material can be an important component. PDMS (polydimethylsiloxane)
based inert polymeric materials are widely used as SPME fiber coatings. For example,
polydimethylsiloxane/divinylbenzene

(PDMS/DVB),
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polydimethylsiloxane/

carboxen

(PDMS/CAR),

polydimethylsiloxane/polyacrylate

(PDMS/PA),

and

polydimethylsiloxane/polyethylene glycol (PDMS/PEG) are commonly used.18 Based on previous
studies18 done in the Todd Mlsna lab to capture the fungal volatiles, a PDMS/CAR fiber was
chosen for all studies involved with volatile chemicals in this dissertation.
1.5.2

Non-volatile metabolites derivatization
Metabolites need to be thermally stable, have low polarity, and be volatile or semi-volatile

for best results using GC-MS analysis.16,30 However, many metabolites that do not have these
properties must be changed for GC-MS detection. Chemical derivatization can be used in GC-MS
to enhance analytes’ volatility, thermal stability, and GC-MS detector response. Derivatization
changes the analyte molecule; therefore, interactions with the GC columns will differ.
Derivatization techniques target the analyte’s most active and polar hydrogen atoms, such as -OH,
-NH, -NH2, -SH, and -COOH.30 Analytes with these mentioned functional groups tend to make
intermolecular hydrogen bonds and reduce the volatility of the metabolite.
Another advantage of derivatization is an enhancement of mass spectrometer detectability
by generating fragment ions that interact with the detector. Derivatizations also help to produce
chromatograms with sharp, narrow, and symmetrical peaks; this is mostly because of the volatility
and stability enhancement resulting from derivatization.31,32 For example, trimethylsilyl ether
fragments produce easily identifiable mass ions. GC-MS targeted derivatization is done primarily
using 3 methods: alkylation, acylation, and silylation. Generally, alkylation is through
esterification, where the active hydrogen of the metabolite is replaced by the alkyl group, making
it less polar. Dialkylacetals, diazoalkales, pentafluorobenzyl bromide (PFBBr), benzylbromide,
boron trifluoride (BF3) in methanol or butanol, and tetrabutylammonium hydroxide (TBH) are
some examples of highly used derivatization agents under this category. Acylation is a process
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that can generate esters, amides or thioesters by reacting with the active hydrogen (OH, NH, or
SH) of the metabolites with carboxylic acid derivatives.33
Silylation is a highly practiced derivatization technique for GC-MS with non-volatile
metabolomics applications. Silation replaces the active polar hydrogen in the metabolite with a
silyl group (commonly the trimethylsilyl group (TMS)). Derivatives produced with this method
are less polar, more volatile, and have higher thermal stability than their native state. The reagents
used

in

silation

are

N-methyl

bistrimethylsilyltrifluoroacetamide

trimethylsilyl

(BSTFA),

trifluoroacetamide

hexamethyldisilazane

(MSTFA),
(HMDS),

trimethylchlorosilane (TMCS), trimethylsilylimidazole (TMSI), bistrimethylsilylacetamide
(BSA), and trimethylsilyldiethylamine (TMS-DEA). MSTFA and BSTFA are the most widely
used silylation agents in metabolomics (Scheme 1.1). Another frequently used silation
derivatization method requires two-steps. In the first step, oximation is done using methoxyamine
hydrochloride (30 mg/mL). This oximation prevents the formation of enol trimethyl esters by ketoenol tautomerism and decarboxylation of ketone groups. Oximation suppresses the ring formation
of the reducing sugars as well.16 Extracted metabolite mixtures should be completely dried because
residue water can hydrolyze the silation reagent. As a precaution, the oximation reagent should be
freshly prepared, and the silation reagent should be capped tightly to produce the desired targeted
derivatives before GC-MS analysis. Excess reagents (>20 µL), reasonable reaction temperature
and duration should be used for a successful derivative.
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Scheme 1.1

MSTFA silation reaction, TMS: (CH3)3Si, X: O, S, COO, R, NR`, NH, R`: Alk,
Ar.

There is a significant disadvantage in the derivatization process when attempting to identify
the native metabolites from biological systems. Derivatization can result in the generation of many
derivatives from one original metabolite, and derivatives can vary with derivatization temperature,
duration and the amount of the derivatization reagent involve with the reaction. Therefore, after
derivatization, one original metabolite can produce several derivatives, leading to errors in
compound identification. Therefore, Xu et al. suggested that derivatization-based GC-MS
metabolomics can be used for discrimination studies but not for biomarker discovery-related
studies.34
1.6

Global metabolite extraction method development
Untargeted metabolomics aims to study the entire metabolome, using one or more detection

methods, therefore, it is essential to extract as many metabolites as possible. The metabolome can
consist of chemicals with a broad lipophilicity range.6 Single solvent or solvent mixtures can be
used to extract the intracellular metabolites in biological systems. Therefore, solvent selection is
dependent on the application of the metabolomics workflow. When selecting an extraction solvent
mix, there are two main criteria to be considered. First, a particular solvent should be able to extract
almost all metabolites. Second, that solvent mix should precipitate almost all proteins present in
the cell lysate.35 Protein precipitation is of great concern as proteins can obstruct the detection of
small molecules with techniques such as mass spectrometry and NMR.35
12

Filtration can be utilized to separate protein molecules from the metabolome, thus avoiding
detection obstacles; however, some metabolites can be retained in filters while passing through the
filters. Therefore, filtration should be minimized between metabolite extraction and detection. The
wisest method is the utilization of a solvent mix that has protein precipitation ability. Methanol,
ethanol, isopropanol, acetonitrile, and butanol are commonly used solvents in metabolite
extraction studies.17,32,35,36 These solvents have different metabolome extraction efficiencies and
protein precipitation efficiency and can be used as a single solvent or mixture. Metabolome
coverage is highly affected by the polarity of the solvent (Figure 1.6)
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Figure 1.6

Solvent polarity variations in metabolite extraction ability.

Solvent polarity variations in metabolite extraction ability. Predicted octanol/water partition
coefficient (X log P) range of common metabolites (data for representative metabolites in blood
plasma and polarity index of solvents used for sample extraction. Typical solvents or solvent
mixtures (in gray color) used in metabolomics and lipidomics indicate the polarity range of
isolated metabolites with high recovery. Extraction ranges increase if ternary mixtures are used
that include water, or if water is added in simultaneous extraction/fractionation procedures
similar to the classic Bligh–Dyeror Matyash–Schwudkeprotocols. Legend: Cer, ceramides; Chol,
cholesterol; CholE, cholesteryl esters; CL, cardiolipins; DG, diacylglycerols; FAHFA, fatty acid
esters of hydroxyl fatty acids; LPA, lysophosphatidic acids; LPC, lysophosphatidylcholines;
LPE, lysophosphatidylethanolamines; MG, monoacylglycerols; PA, phosphatidic acids; PC,
phosphatidylcholines; PE, phosphatidylethanolamines; PG, phosphatidylglycerols; PI,
phosphatidylinositols; PS, phosphatidylserines; PUR, purines; PYR, pyrimidines; SM,
sphingomyelins; TG, triacylglycerols; TMAO, trimethylamine N-oxide.6 Reprinted from Cajka,
T.; Fiehn, O. Toward Merging Untargeted and Targeted Methods in Mass Spectrometry-Based
Metabolomics and Lipidomics. Anal. Chem. 2016, 88 (1), 524–545. Copyright © 2016 American
Chemical Society.
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A system’s metabolome consists of metabolites with a wide polarity range, from
hydrophilic to lipophilic.6,37 Metabolites can be categorized into primary and secondary
metabolites. Primary metabolites are essential for the growth, development, and reproduction of
the organism.38,39 Even though the secondary metabolites are not directly related to the primary
metabolism of the organism, they can provide a snapshot of what is currently happening in the
organism. Information regarding defense mechanisms, nutritional level, or response to
xenobiotics, can be gleaned from their analysis. Secondary metabolites can be alkaloids, steroids,
phenolics, polyamines, terpenes, etc.38 Solvent selection can be made to ensure extraction of
particularly interesting metabolites, or class of metabolites, required to answer specific study based
questions.
Conventional polar metabolites extractions are based on methanol (100%) or methanol and
water mixtures (1:1, 4:1, v/v)6,40,41. In contrast, the non-polar metabolites are extracted using
liquid-liquid extraction methods (LLE) using biphasic Folch, Bligh-Dyer, and Matyash methods.
The Folch method uses a chloroform-methanol mixture (2:1)42 to extract non-polar metabolites
and the Bligh- Dyer method begins extraction with a chloroform-methanol mixture (1:2) followed
by addition of equal volumes of chloroform and water.43 Even though these methods were
introduced in the 1950’s they are still often used in lipidomics workflows due to their extraction
efficiency of non-polar metabolites. The disadvantages of these methods are the toxicity and
carcinogenicity of the chloroform and low recovery and reproducibility of the lipid fraction.
Chloroform can be replaced by dichloromethane (less toxic) in these methods to extract the nonpolar metabolites.44
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Extraction is due to phase separation between the polar liquid fraction, middle protein
fraction, and the apolar liquid fraction. Long tip Pasteur pipettes can be used to collect the bottom
apolar (chloroform) fraction after the pipette passes through two layers to reach the non-polar
metabolite-rich chloroform layer. Recovery and the reproducibility of the non-polar metabolites
can be affected by the extraction.
The Matyash method was introduced to overcome the technical difficulties of harvesting
the highly dense lipid fraction in the methods described above. In this Matyash method, methyltert-butyl ether (MTBE) is used instead of chloroform, and it is less dense than methanol. In this
method, MTBE, and methanol (5:1.5, v/v) are involved with the lipid extraction, and then the
introduction of the water (MTBE/methanol/water, 10:3:2.5, v/v/v) induces phase separation.45 In
this protocol, MTBE forms the upper layer in the biphasic system, allowing for easier extraction
of the lipid-rich MTBE layer. In the Matyash method, the protein fraction deposits in the bottom
of the tube after centrifugation. Even though this Matyash method allows for cleaner lipid fractions
compared to the lipid extraction protocols described above, recovery (especially of the amphiphilic
compounds) and reproducibility are still affected due to the biphasic system.
IPA (isopropanol 100%) was used in untargeted lipidomics of blood plasma, and it
demonstrated a higher protein precipitation efficiency than the other common solvent extraction
methods. IPA also showed broad applicability in metabolite extraction from non-polar to polar
metabolites in human blood plasma and mammalian cells.35,41 Alshehry et al. reported a singlephase extraction method to extract plasma lipid using butanol and methanol (BUME) (1:1, v/v).
An advantage of this technique is that there is no need to dry the extracted liquid fractions with an
MS (LC-ESI-MS/MS) compatible solvent.46
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1.6.1

Quality control in metabolomics workflows
Quality assurance (QA) and quality control (QC) in the metabolomics workflow are critical

because findings should be reproducible in cross laboratories and or future researchers.6,47
Metabolomic workflows are applied in clinical research for biomarker discovery in complex
biological matrixes such as in urine, blood, plasma, or even in plant or microbial mixtures or when
assessing a drug's performance for a specific function. QA is involved before implementing the
metabolomics workflow, such as instrument calibration, scientist training on instrument handling,
and sample preparation. QC is involved with pre and post-data acquisition with an analytical
instrument.47 QC is of utmost importance in enhancing the reliability of the method by reducing
analytical variance and allowing for the collection of high-quality data.
As noted in section 1.3, targeted metabolomics focuses on the identification and
quantification of a few metabolites. Therefore, general analytical method validation criteria such
as accuracy, precision, limit of detection (LOD), the limit of quantification (LOQ), linearity,
specificity, and range are considered.48 Standard compounds or label isotopes are used in targeted
metabolomics for more accurate and precise quantification. Method validation method in
untargeted metabolomics is quite different because metabolites are not quantified as in targeted
metabolomics. With untargeted metabolomics, scientists only check the method fitness or
suitability for the intention of the study.49 QC samples can be used in metabolomics to assess
sample preparation and analytical variability at the pre data processing stage.
Relative standard deviation (RSD) univariately measures the precision of the analysis
between runs within the experiments. PCA as a multivariate type of analysis: shows the variability
associated with the analytical runs with the experiment.50 Figure 1.7 shows how the QC samples
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have been used in testing the analytical workflow in an untargeted metabolomics application
described in chapter 2 of this thesis. For smaller sample sets, the QC sample would be mixtures of
portions of the samples, ideally representative of the entire sample. However, large sample sets
that require thousands of samples over extended periods may need to be frozen to ensure the
sample's integrity is not lost.48 Theoretically, QC samples should contain all the detected
metabolites in the samples of a particular experiment. Aliquots pooling can be done to prepare QC
samples. Then this pooled sample can be sub-aliquoted to several vials, stored at -80 °C, and use
during the experiment intermittently.50

Figure 1.7

PCA score plot of test VOC samples with the QC VOC samples, each blue dot
represents the test sample, and red triangle represents the QC samples. QC samples
are flocked together. Hence the data generated from the analytical platform is
reliable.
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Chapter 2 and part of Chapter 3 in this thesis used an untargeted metabolomics workflow
of volatile organic compounds. QC samples were used to monitor variations associated with the
HS-SPME GCMS workflow. The rest of the studies used the pooled sample QCs to test the
analytical performance of the derivatization followed GC. The benefits of the QC samples, besides
the system variability checking, are that initial (for LC, n = 5-10 and GC, n = 5) QCs can be used
to condition the column and detector response.51 A typical injection order of the test samples and
QC samples are illustrated in Figure1.8. Signal correction, which happens due to instrumental
error, can be evaluated with QC samples injected at the end of the experiment. Moreover,
standardization of the workflow, signal intensity integration, and the normalization (intensity
correction) of the test data can be done relative to the QC intensities.52

Figure 1.8

Sample injection order of a metabolomics workflow
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QC samples can be made in different ways. Pool QCs (described above) are the most
widely used QC samples. Sometimes pooling of the samples may be impossible or hard to perform,
such as in large-scale studies occurring over the years or in cases involving real-time monitoring
of the volatiles. Chapter 2 in this thesis is an excellent illustration of a different way of making QC
samples. Chapter 2 involved a disease-related volatile organic compounds assay utilizing liquid
extraction of diseased and healthy sweet potatoes with samples stored at -80 °C; aliquoted liquid
samples were used as QC samples for the study. Apart from the pool QC samples, reference
standard materials, if available, can be used.
In targeted metabolomics approaches, sample spiked isotope-labeled targeted species or a
mixture of labeled compounds can be used to determine the accuracy and precision of the
workflow. The ideal way to measure workflow accuracy is the usage of the isotopic dilution
method. In that method, an isotopically labeled metabolite is spiked at different concentrations into
the sample at the extraction step and then subjected to mass spectrometric analysis. The calibration
curve approach, with targeted metabolite standards, can be used to measure the accuracy and
precision of that workflow.53
1.7

Bioinformatics and chemometrics in metabolomics
In untargeted metabolomics, the important metabolites defined in the post-acquisition

phase and the significance in specific biological pathways are studied to understand phenotype
variation or to obtain biologically meaningful information.54 This often requires significant data
pre-treatment and statistical analysis. Data analysis provides confidence in the biological
interpretation of the acquired data, applied in every step in the metabolomics pipeline, including
experimental designing.55,56 Untargeted metabolomics workflows generate thousands of MS data
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sets that are difficult to manage manually. Therefore, there is a need for bioinformatics tools
such as software programs and machine learning algorithms to analyze the data.57 Due to the
diversity and the complexity of the metabolites covered in metabolomics, these software tools
are constantly evolving to have more precise and accurate data analysis. Chemometrics provides
statistical and mathematical tools that can be applied to reach conclusions from the data collected
on chemical systems.58 The use of bioinformatics and chemometrics tools collectively enables
phenotype differentiation, biomarker discovery, and method optimization in the metabolomics
workflows.
1.7.1

Data pre-treatment
Before going deeper into the data analysis, all the hyphenated mass spectrometry acquired

data should be pre-processed. The output of MS detection is m/z values, but when it is coupled
with any hyphenated technique, the results become three-dimensional; m/z, retention time (RT),
and intensity values.59 This 3D format needs to be converted into a 2D structure (data table with
all raw values) before applying any further analysis. First, the RT values needed to be aligned.
This is more critical in untargeted metabolomics because it involves comparing two data sets, such
as the treated/perturbated group and the control or baseline group. GC or LC-MS instruments
always have some instrumentation drift resulting in RT drift which can arise with temperature or
pressure fluctuations in the system or may be due to changes in the analyte/stationary phase
equilibrium.60 This RT drift needs to be corrected, and the RT aligned for all m/z values before
any comparison. After RT alignment, the data matrix with RT, m/z values, and peak intensities is
ready for further data processing methods.
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1.7.2

Statistical analysis
As emphasized in previous sections, statistical analysis is the most critical and challenging

step in metabolomics. Pattern searching, group or phenotype differentiation, and biomarker
discovery can be difficult. For best results it is essential to utilize large volumes of acquired data
before biologically meaningful information can be acquired. Statistical analysis of metabolomics
can be divided into distinct phases: data pre-processing and post-processing. First, RT alignment
and noise and outlier filtered data matrix can be subjected to the missing value imputation.
Typically, mass spectrometry-based metabolomics workflows generate nearly 20% of the missing
values, and these missing values should be filled before any statistical analysis.61 The missing
values imputation method in metabolomics and lipidomics replaces missing values with either
zeros or one half of the lowest value in the dataset. Statistical analysis is done in two ways, using
univariate or multivariate analysis, depending on the objective of the analysis.
Untargeted metabolomics often uses a complete data analysis procedure. First, dataset pretreatment by centering, scaling, and normalization. Then predictive model building and validating
those models, finally, biological interpretation by analyzing the relevant biochemical pathways.
However, this order could be changed based on the goal of the metabolomics approach.14 Disease
diagnosis biomarker investigation is a highly data-driven process. Therefore, it is critical to assess
the accuracy and the performance of the predictive models.
The traditional way of compound identification with hyphenated mass spectrometry is
based on matching unknown retention time and mass spectra with standard compounds. This can
also be applied to targeted metabolomics studies, but manually resolving and identifying each peak
in untargeted metabolomics is infeasible due to the presence of thousands of peaks. Thus, it
becomes critical to use suitable mathematical and computational strategies to resolve peaks in
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untargeted metabolomics. Multivariate chemometric data analysis often plays a vital role in
untargeted metabolomics workflows.
1.7.2.1

Univariate analysis
One variable (feature) analyzing at a time is univariate analysis, the interaction between

variables is not considered, and the analysis of the feature is summarized on its own.62 ANOVA,
t-test for different sets of sample comparison, and fold change analysis fall under the univariate
analysis. In those cases where normality of the data cannot be assumed, non-parametric tests such
as Mann–Whitney U test or Kruskal–Wallis one-way analysis of variance are preferable.
1.7.2.2

Multivariate analysis
In contrast to univariate analysis, multivariate analysis is performed when the experiment

involves two or more variables.62 Therefore, multivariate analysis can be effectively used to
support the core idea of untargeted metabolomics: to resolve the complexity of the metabolome or
metabolome alterations by using thousands of acquired data. In this multivariate analysis, all
variables (features) are analyzed simultaneously, and their interactions are determined.62
An initial step of the multivariate analysis can be PCA (Principal Component Analysis)
which is categorized as an unsupervised algorithm. Unsupervised methods use the unlabeled data
(data without any tags such as name, number, or type). PCA can be used to visualize interesting
patterns in hidden data, clustering, dimensional reduction, etc. HCA (Hierarchical Cluster
Analysis) is another unsupervised type of analysis. Supervised machine learning uses labeled data
(such as data with tags like name, type, or number). Supervised methods use metabolite features
to categorize and visualize the associated patterns in the data set.63 PLS-DA (Partial Least Square
Discrimination Analysis), OPLS-DA (Orthogonal Partial Least Square Discrimination Analysis),
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RF (Random Forest), SVM (Support Vector Machines) are some of the more popular supervised
machine learning techniques in untargeted metabolomics.63
In supervised modeling, a training data set is created using collected data. This training
data set has input information and the requested final output, which guides the models to get the
wanted result based on the information in the feed data set. Therefore, prediction accuracy and the
precision of the supervised methods need to be reported, especially in biomarker discovery-related
studies. The final step is the pathway analysis of the putative biomarkers or metabolites responsible
for group differentiation.
1.7.3

Metabolite annotation
Metabolite annotation or metabolite identification is a bottleneck in untargeted

metabolomics workflow. This metabolite identification step can be performed right after data
processing and would be less complicated after the initial data analysis. The basic of the metabolite
annotation is to filter the information from the noise in the acquired data and ultimately guide it to
the biological interpretation of the data. The idea in untargeted metabolomics is to identify as many
metabolites as possible in the biological sample. There is no compiling of the metabolites in
targeted or semi-targeted metabolomics because the metabolites involved in these workflows are
small in numbers, and their authentic compounds can be used to verify the retention time or the
MS spectrum.
The Metabolomics Standards Initiative (MSI) has announced some fundamental facts
regarding reporting of detected metabolites in metabolomics studies.64 According to the guidelines
of MSI, there are four levels of metabolite or chemical identification. Namely,
1.

level 1: compounds identification with their standard chemicals

2.

level 2: compounds identification by spectral database matching
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3.

level 3: only the chemical class or group identification

4.

Unknowns

The level of identification should always be reported. When working with the disease
biomarker models, level 1 identified metabolites are highly encouraged because these
metabolites/biomarkers will be used for future studies, helping to control or eliminate diseases.
Level 1 identified compounds should be verified with the spectra of their standard or reference
materials, and that should be done with the same laboratory with the same analytical platform.53
A standard spectral comparison with the different laboratories or literature is considered to be level
2 identified putative metabolites. It is often difficult to perform level 1 identification of the
metabolites because they are not always commercially available. Some commercial laboratories
will synthesize the metabolites upon the requests. In-silico mass spectral libraries can be helpful
when commercial standards are not available. Level 2 identification is based on library-matched
information. In level 3, metabolites are identified as the compound class based on functional
groups or physicochemical or spectral similarities of the related chemical class. Identified
unknowns are categorized as level 4 in the identification process. The metabolites in level 4 are
named unidentified compounds because no evidence exists in spectral libraries. They may be
unknowns, but they are essential because they can be novel compounds, and their spectral data can
be used for their identification.65
Figure 1.9 outlines the required steps involved in the untargeted metabolomics workflow.
Raw GC-MS data (retention time (RT) and mass spec (MS) data) was converted into the NetCDF
format. Data pre-processing was carried out using a web-based platform: Global Natural Product
Social (GNPS) molecular networking analysis platform. GNPS uses a machine-learning algorithm:
MSHUB, to auto-deconvolute EI fragmentation patterns. The algorithm takes in RT and MS data
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and applies several processing steps, including spectra alignment, noise filtering, baseline
correction, and RT alignment, to quantify the reproducibility of fragmentation patterns across
samples. Peak deconvolution is a separation of overlapping peaks across the sample and is
important because it reconstructs a pure mass spectrum for each chemical. The pure spectrum is
ultimately used for identification. Peak deconvolution is done using ‘unsupervised non-negative
matrix factorization’ which is part of the web-based MSHUB software packet.66 The data matrix
can then be downloaded from the GNPS platform, and this data can be used for statistical analysis.
The statistical analysis involved in this thesis was carried out using SIMCA-P+ and or
MetaboAnalyst platform.
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Figure 1.9

GC-MS based untargeted metabolomics data handling workflow

The GC-MS raw data can be exported in NetCDF format, and then preprocessed to generate a
data matrix with features and peak intensities for the further data analysis. The reliability of the
GC-MS generated data can be checked by ploting with test samples with QC samples. Then the
data can be initially visualized with PCA and HCA and then classification models can be used to
determine significant features. Finally biological meaningful information can be gathered using
the above mentioned significant features and pathway analysis results.
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CHAPTER II
VOLATILE BIOMARKERS FOR EARLY STAGE DISEASE DIAGNOSIS OF SWEET
POTATO FUNGAL SOFT TISSUE DISEASE
2.1

Introduction
Several assays and detection platforms have been utilized to analyze volatile organic

compounds (VOC) associated with plant and fungi interactions, plant related fungal diseases, and
fungal or microbial infection during post-harvest storage conditions. These methods have been
used to identify parameters for disease regulation and track disease propagation67,68. These findings
could ultimately lead to the invention of smartphone detection system-based gas sensors, or Enose applications for the plant-based disease diagnosis.69,70 These devices have shown some
capacity to diagnosis disease in many fields including plant disease detection.71 E-noses could
serve in volatile compound sensing applications where the cost of traditional methods of analysis
prohibit use. E-noses work by collecting and impinging VOCs from the air upon an applicationspecific sensor. This process is referred to as artificial olfaction due to its functional similarity to
mammalian olfaction. The emission of plant VOC is often used in communication for signaling
between parts of a plant, between plants (intra and interplant species), a defensive mechanism for
pathogens, and for attracting pollinators and seed dispersers.72 The composition of the VOCs
associated with plant metabolomics is highly variable due to plant physiological and dynamic
ecological factors, especially abiotic or biotic stress can alter a plant’s volatile profile.73
Collecting volatile compounds, especially in the field, is often the most challenging step in
the analysis of the volatile organic compounds because these compounds are present in the
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atmosphere at very low concentrations.74 The selection of trapping media is an essential part of
this process. There are several methods for the trapping volatiles, however, for this application,
headspace solid-phase microextraction (HS-SPME) is considered to be superior to solvent
extraction methods as it is a non-destructive method.73 Real-time headspace VOC analysis gives a
snapshot of the biosynthesis occurring at the sampling time; hence it is beneficial for field analysis
of VOC emissions.
Microbial VOCs (MVOCs) are VOCs produce through an organism’s biosynthetic
pathways as a part of their metabolism. Generally, these VOCs have low boiling points, high vapor
pressures and are transmitted long distances through the air or underground.72 These volatile or
semi-volatile compounds are often small molecules lipophilic metabolites and or their
derivatives.75 MVOCs consist of alcohols, aldehydes, alkenes, ketones, organic acids, esters
terpenoids, benzenoids, fatty acid derivatives, and nitrogen and sulfur-containing compounds.72,75
Changes in metabolism can be tracked with a metabolomics workflow approach. The volatile
nature of these small molecules/secondary metabolites allows them to be targeted as possible
biomarkers of sweet potato fungal soft tissue disease.
Sweet potato is a primary global food source and is cultivated in more than 100 countries
worldwide. Due to its extensive production, there is harvest excess each year that needs to be stored
in large-scale warehouses. Storage can cause postharvest decay which shortens the sweet potato
shelf life due to the rotting initially caused by the fungal infection. Fungal soft tissue disease caused
by Rhizopus stolonifer is one of the major postharvest diseases in the sweet potatoes industry. This
study focuses on analyzing the volatile profile produced from the Rhizopus stolonifer infected
sweet potato tissues to identify biomarkers for the diagnosis of fungal disease.
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2.2
2.2.1

Method
Bio and plant materials
Sweet potatoes (Orleans cultivar) were collected in mid-October 2020 from Pontotoc

Ridge-Flatwoods Branch Experiment Station at Mississippi State University. All sweet potatoes
were washed with running water to remove soil and then stored overnight to air dry. The potatoes
were then surface sterilized with 2% sodium hypochlorite for 2 min before being washed three
times with sterile distilled water. The sweet potatoes were then dipped in 75% ethanol for 40
seconds and washed three times with sterile distilled water. R. stolonifer (Rhi 003) was obtained
from the Dr. R. Baird culture collection stored at –80 °C. R. stolonifer fungi were grown on potato
dextrose agar (PDA) plates. To ensure maximum infection potential by the fungal isolate, a sweet
potato was infected with 3 days old PDA grown fungi plugs and incubated at 37 °C for 3 days to
ensure tissue infection. Fungal hyphae grown on the potato were aseptically obtained and cultured
on PDA plates. This method activates all hibernated bioactivities associated with –80 °C storage
conditions.
The newly grown R. stolonifer was used as the inoculum for VOCs analysis. Surface
sterilized sweet potatoes were punched with a 2 mm cork borer in the middle, distal and
proximal ends of the sweet potato. The fungi-infected sweet potato was placed in a sterile glass
container (500 mL), lined with pre-wetted sterile paper towel round pads (to maintain humidity
for fungal growth). There were five replicates of infected sweet potatoes used in the analysis.
The same number of sweet potato replicates were used as controls, and the same procedure was
repeated except the placing of fungal plugs. VOCs were extracted at 1, 2, 3, 4, 5, 7, 10, 14, 21,
and 28 days after inoculation. Carboxen/polydimethylsiloxane (CAR/PDMS 85 µm) fibers
(Sigma-Aldrich, St. Louis, MO, USA) were used to extract the evolved VOCs.
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2.2.2

Fungal MVOC analysis
R. stolonifer MVOCs were analyzed during growth in 15 mL basal media in a flask (25

mL) which was capped and sealed with aluminum foil and parafilm. Eleven replicates of three
day old, seven of six day old (sporulated fungi) and 10 of control basal flasks were used to
analyze the MVOCs of the R. stolonifer.
2.2.3

Confirmation of biomarkers in a simulated warehouse environment
Surface sterilized sweet potatoes (80) sweet potatoes from the same batch used for the in-

situ VOC experiment) were stored in a simulated warehouse space located at the Pontotoc RidgeFlatwoods Branch Experiment Station. Four control boxes and four disease monitoring boxes were
prepared. Each box had 10 sweet potatoes, and 50% of the sweet potatoes (5) in the disease
monitoring box were infected with R. stolonifer fungal plugs. These infected sweet potatoes were
incubated at Mississippi State University (MSU) for 3 days before moving to the Pontotoc research
station. This incubation period minimized the dislodging of fungal plugs during travel.
PDMS/Car fibers were situated above the sweet potato storage boxes for 48 hours to extract
emitted VOCs and brought to MSU for GC-MS analysis. VOC sample loss was minimized by
taking some precautions. Briefly, VOC extracted fibers were sheathed and capped, wrapped with
aluminum foil separately, placed in a glass box and then put in a cooler box with ice while traveling
to minimize VOC sample loss.
2.2.4

Quality control (QC) of the SPME-GC/MS analysis
QC samples were prepared using R. stolonifer infected sweet potatoes as described below.

First, fungi-infected sweet potatoes were flash-frozen with liquid nitrogen before crushing with a
mortar and pestle. Next, 125 g of the ground sweet potatoes were extracted into 125 mL of sterile
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DI water with stirring (2 min) followed by centrifuging (3000 rpm, 5 min), and then the supernatant
was aliquoted (400 µL) into 1 mL GC-MS vials and stored at –80 °C. These QC samples were
analyzed randomly during this study to assess the performance reliability of the HS-SPME GCMS analytical platform.
2.2.5

GC/MS analysis
Qualitative analyses of VOCs were performed on an Agilent 7890 A gas chromatograph

(Agilent technologies, CA, USA) coupled with an Agilent 5975 C triple-axis mass detector
(Agilent technologies, CA, USA). Volatile metabolite separation was performed on a 60 m DB-1
column with 0.32 mm inner diameter and 1 μm film thickness (Supelco, Bellfonte, CA,
USA). SPME fibers were manually injected into the GC inlet port and desorbed for 5 min at 280
°C in the splitless mode.
The GC temperature program started at 45 °C, followed by a 3 °C min−1 ramp to 75 °C,
held for 2 min at 75 °C, the temperature was then ramped to 110 °C at 5 °C min−1 and held for 2
min finally the temperature was ramped at 15 °C min−1 to 270 °C and kept for 3 min. The total
GC/MS run time was 36.667 min with 2 minutes of solvent delay. The transfer line, electron impact
(EI) (70 eV) ion source, and quadrupole temperatures were set at 250, 230 and 150 °C,
respectively. Mass spectra were recorded at two scans per second with an m/z 35–350 scanning
range.
2.2.6
2.2.6.1

Statistical analysis
Data pretreatment before the chemometric analysis
Raw GC-MS data files were exported in the NetCDF (network common data form) format

using Agilent ChemStation and uploaded into the GNPS (Global Natural Products Social
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Molecular Networking) (https://gnps.ucsd.edu) for peak detection, deconvolution, and alignment
with default settings for GC/MS-EI data processing. A feature table was downloaded from GNPS,
and the data matrix (feature identities and peak intensities) was organized in a Microsoft Excel
(Microsoft, Redmond, USA) spreadsheet. Primary data filtering was applied using the “20%
rule”.76 This rule is generally used in biomarker analysis to retain the chemicals which are present
in at least 20% of the samples in one group. Features with a similar retention time were evaluated
with the Pearson correlation to correct the misidentification of the peaks because single peaks can
be split into multiple features during deconvolution. Features with overlapping retention times and
significant mass spectral correlation (r2 > 0.7)77 were determined to be a single compound. For the
peaks with isomeric stereo forms, the peak which had the highest peak area was retained. Features
that contributed to group separation (control vs. infect) were initially identified using univariate
analysis (Mann Whitney test). Features with p > 0.1 were manually removed, and the others (p <
0.1) were used for the compound annotation and further statistical analysis.78,79
Multivariate analysis was performed using SIMCA-P+ software omics skins (V15.0,
Umetrics AB, Umeå, Sweden). The dataset was normalized by sum, log-transformed, and Pareto
scaled before the multivariate analysis. Principle component analysis (PCA) was used for initial
group separation as an unsupervised method. A supervised method, orthogonal projections to
latent structures discriminant analysis (OPLS-DA), was used for biomarker selection.77 The
performance of the selected features was evaluated with receiver operating characteristic (ROC)
curve analysis (AUC-ROC) analysis. ROC curves and correlation matrixes were constructed using
a MetaboAnalyst 5.0 platform.80
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2.2.6.2

Metabolites identification and biomarker selection
Metabolite identification was carried out at different levels defined by the Metabolomics

Society who governs the Metabolomics Standard Initiative (MSI).53 Briefly, level 1 metabolites
are identified using identical standard chemicals, level 2 metabolites are identified using database
matching (GNPS or NIST 08), level 3 identifies the compound class, and unknown features are
considered to be level 4 metabolites. In this study, features were classified into levels 1, 2, 3, and
4; there were no metabolites associated with level 3. Metabolite identification was initially made
using the GNPS GC-MS library search.81 The minimum library match score for significant hits
was set to 0.8, and features selected from the Mann-Whitney test (p-value < 0.1) were used for
metabolite annotation. The mass spectra of the identified putative metabolites were further
compared with a mass spectral database (NIST 08, Agilent Technologies, Inc.) installed in the GCMS used for analysis. Furthermore, some of the significant compounds were verified from mass
spectra and retention times of their authentic compounds. Putative biomarker selection was made
using OPLS-DA models.
2.3

Results and Discussion
Volatile profiles of R. stolinifer infected and non-infected sweet potatoes were analyzed to

identify biomarkers for the diagnosis of Rhizopus fungal soft tissue disease. Figure 2.1 shows the
two stages of Rhizopus fungal soft disease propagation. The visual observation of disease
progression throughout 28 d was summarized in the supplementary information (Table A.1).
Figure 2.1 shows the R. stolonifera infection on sweet potatoes at different stages.
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Figure 2.1
2.3.1

R. stolonifera infection on sweet potatoes at different stages

Reliability of the analytical platform
There were 96 unique spectra acquired from the HS-SPME GC-MS used for the

discrimination of fungal infected sweet potatoes from the healthy (control) sweet potatoes. The
analytical performance of the large-scale GC-MS-based workflow was evaluated by using QC
samples which were prepared according to section 2.2.4. PCA was carried out with all samples
and QC samples to evaluate the performance of the analytical platform. All the QC samples are
grouped together (red triangles) in the PCA score plot (Figure 2.2). The analytical platform (HSSPME GC-MS) had good retention time repeatability (SD ≤ 0.02) (Appendix A2).
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Figure 2.2

PCA plot for QC samples (red triangles) and VOC samples (blue circles)
(R2X = 0.483, Q2 = 0.162 A = 5 N = 121). Each point displayed in the PCA score
plot represents a sample, and the distance between the points is an indication of
sample similarity of stolonifera infection on sweet potatoes at different stages.
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2.3.2

Discrimination of the metabolite profile of the fungal infected sweet potatoes from
non-infected sweet potatoes
All 96 collected spectra were used to help identify biomarkers of fungal soft tissue disease

in the sweet potatoes. All the chemicals found in the control and diseased sweet potatoes (P-value
< 0.05, Mann Whitney test) are listed in Table 2.1. The pre-processed data matrix was initially
subjected to unsupervised projection analysis: PCA to visualize the group separation between the
control and disease groups (Figure A.1). It clearly showed the separation of the disease group from
the control group. To enhance the separation of two groups, supervised analysis: OPLS-DA was
applied. The score plot of the OPLS-DA, shown in Figure 2.3 a, has better separation of the disease
from the control groups. The metabolites responsible for the above group separation were obtained
using an S-Plot from the OPLS-DA model (Figure 2.3 b). A descriptive summary of the OPLSDA model used for the putative marker selection can be found in SI Figure 2. The explained
variance (R2 = 97.9%) of the model and the predictive ability or accuracy (Q2 = 94.1%) of the
OPLS-DA model was more than 90%. The features which contributed to group separation in the
OPLS-DA model were selected using the VIP (VIP > 1.5) and P (corr) (P (corr) > 0.5) value of
those features. The importance of the x variable to the classification model can be expressed by
the P (corr) value. Fourteen features were identified as putative markers of disease propagation for
fungal soft tissue disease (Table 2.2).
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Table 2.1

Volatile organic compounds released from the healthy and infected sweet potatoes
during the fungal disease propagation
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37

Compound
dl-Alanyl-dl-leucine
l-Alanine ethylamide, (S)dl-Alanyl-l-alanine
Acetic acid ethenyl ester
Propyl acetate
Ethyl alcohol *
2-Hexanol
N,N,O-Triacetylhydroxylamine
Acetic acid allyl ester
Cyclobutylamine
Hordenine
1-Propene, 2-methoxyAcetic acid, methyl ester
Diacetyl sulphide
2-Butene, 2-methyl1-Heptanol
2-Pentene, (E)Glyoxylic acid
1,3-Pentadiene, (E)1-Propanol *
Allyl acetate
2,4(3H,5H)-Furandione
2-Butenal
Isopropyl acetate
2-Butanone
1-Allyl-1-methylhydrazine
Propanenitrile, 2,2-dimethylAcetic acid ethyl ester
Ethyl Acetate *
Butane, 2,2,3,3-tetramethylTrichloromethane
Furan, 3-methylButane, 2,3-dimethylPropane, 1-chloro-2-methylCyanamide, dimethylMethacrolein
Methyl isopropyl ketone
38

RT(min)
3.73
3.83
4.30
4.43
4.51
4.81
4.90
4.90
5.13
5.18
5.18
5.57
5.77
5.89
5.89
5.95
6.00
6.05
6.05
6.29
6.38
6.60
6.60
6.88
7.04
7.28
7.49
7.49
7.64
7.81
7.86
7.91
8.03
8.10
8.52
8.52
9.06

Table 2.1 (continued)

38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75

Compound
3-Methyl-1-pentanol
Pentanoic acid, 4-oxoMethylthiomethyl p-tolyl sulfone
Phosphine oxide, (chloromethyl)dimethyl2-Pentanone
1H,1H,2H-Perfluoro-1-octene
Formic acid isobutyl ester
3-Pentanone
(S)-Isopropyl lactate
Heptane, 3-methylene3-Methylcyclopentanone
Furan, 2-ethylEthylene glycol dibutyl ether
Butanenitrile, 2-methylEthyl propionate *
Methyl N-pentyl ether
2-Cyclopenten-1-one, 3-methyl3-Butenol
2-MethylButane
3-Buten-ol,3-methyl- (Iso prenol)*
3-Methyl-1-butanol
Allyl isovalerate
2-Methylheptane
2-Pentanol, 4-methylIsopropyl isobutyrate
Cyclopentane
Prenol *
Isobutyl acetate
Methanesulfanilide
Toluene
Benzyl iodide
2-Propanol, 1,1,1-trichloroCyclohexanone
Isopentyl isovalerate
Methyl-2-Acetoxyheptanoate
Triacetin
trans,trans-3,5-Heptadien-2-one
4-Methylpentan-2-one
39

RT (min)
9.26
9.45
9.56
9.77
10.00
10.17
10.27
10.39
10.52
10.72
10.95
11.04
11.09
11.09
11.17
11.20
11.66
11.97
12.13
12.07
12.30
12.49
13.11
13.60
13.66
13.93
14.29
14.32
14.43
14.43
14.53
14.53
14.72
14.72
14.72
14.85
14.92
14.92

Table 2.1 (continued)

76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110

Compound
1,3-Pentadiene, 2,4-dimethyl3-Penten-2-one, 4-methylEthyl butanoate
Dibutyl ether
Isobutyl propionate
Acetic acid, butyl ester
2-Oxo-4-phenyl-6-(4-chlorophenyl)-1,2dihydropyrimidine
Eicosane
2-Methylcylcohexanone
2-Dimethylpropionic acid chloromethyl
ester
Cyclopentane, methylEthyl crotonate *
Naphthalene, 1,2,3,4-tetrahydro-6-methoxy2-Hexenal
Propanoic acid, 2,2-dimethyl-, ethyl ester
Ethyl isovalerate *
2-Sec-butyl-1,1-dimethylhydrazine
3-Hexen-1-ol, (E)Thiophene, 3-methylMethyl tiglate
Ethanone, 1-(1-cyclohexen-1-yl)1-Hexanol
3,3-Dimethoxypropiophenone
1-Butanol, 3-methyl-, acetate
2,5-Furandione, dihydro-3-(2-methyl-2propenyl)Heptane, 2,4-dimethyl2,2-Dimethylpropanoic anhydride
2-Heptanone
Urea
4-Methyl-2-pentyl acetate
Alpha-Hydroxyhippuric acid
Methyl 2-furoate
Anisole *
Tetradecane
2-Butenoic acid, 3-methyl-, ethyl ester
40

RT (min)
15.21
15.46
15.72
15.86
16.15
16.36
16.56
16.64
16.80
17.36
17.60
17.77
17.92
18.06
18.45
18.54
18.60
18.60
18.67
19.07
19.10
19.23
19.34
19.65
19.75
20.04
20.08
20.23
20.65
21.03
21.51
21.79
21.88
21.92
22.08

Table 2.1 (continued)

111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144

Compound
Butanoic acid, 3-hydroxy-, ethyl ester
Benzene, (1-methylethyl)Ethyl tiglate
Sorbic acid vinyl ester
4-Hydroxytropolone
Furan, 2,5-dihydro1-Hexanol, 4-methyl-, (S)4,4-Dimethyl-1-hexene
Alpha-Pinene
Hippuric acid
1,9-Decadiyne
exo-2-Bromonorbornane
(1R)-2,6,6-Trimethylbicyclo[3.1.1]hept-2ene
7-Methyl-1,6-octadiene
Butanone
Furan, 2,3-dichlorotetrahydroPhenol
Benzene, 1,2,4-trimethyl5-Hepten-2-one, 6-methylEthyl 3-furoate
Bicyclo[3.1.1]heptane, 6,6-dimethyl-2methylene-, (1S).beta.-Myrcene
Diallylhydrazone acrylaldehyde
Citraconic acid
2-Carene
Carbonic acid, allyl 2,3-dichlorophenyl
ester
Benzyl alcohol
Valerylglycine
2-Butenoic acid, 3-hexenyl ester, (E,Z)3-Methyltetrahyrofuran
N-Methyl-D-aspartic acid
Bicyclo[3.1.1]hept-2-ene, 6,6-dimethyl-2[2-(phenylmethoxy)ethyl]-, (1S)Isophytol
l-Menthone*
41

RT (min)
22.31
22.68
22.77
22.99
23.04
23.09
23.09
23.18
23.18
23.22
23.33
23.58
23.58
23.72
23.90
23.95
24.06
24.41
24.48
24.79
25.07
25.16
25.35
25.35
25.57
25.75
25.92
26.17
26.37
26.47
26.65
26.77
26.86
26.86

Table 2.1 (continued)

145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181

Compound
Hexane, 3-ethylMesitylene
Acetophenone
Hexadecane
Isophorone
D-Campholic acid
Heptyl tetradecyl ether
trans-2-Heptenyl acetate
N-butyl isopentyl ether
Guanine
Pentane, 2,2,3,4-tetramethyl(3E,7E,11E)-1-Hydroxy-1-isopropyl-4,8,12trimethylcyclotetradecatriene
9-Decenoic acid
2(3H)-Furanone, 3-bromodihydro4-Bromo-1-butene
Decyl heptyl ether
Linalool
Fenchone
2-Propenal, 3-phenylBenzaldehyde, 2,5-dimethylCis-rose oxide
Hexadecane, 1-chloro3-Hydroxypyridine monoacetate
Allyl 2,4-hexadienoate
10-Undecenoyl chloride
Nerol
Propyl ether
3-Decanone
Heptane, 3-(bromomethyl)4-Ethylbenzoic acid
Undecylenic acid
Benzene, (1-bromoethyl)Benzaldehyde, 4-(1-methylethyl)Tetradecanal
2,6-Octadien-1-ol, 3,7-dimethyl-, (Z)Octadecane
Geraniol
42

RT (min)
26.90
26.90
26.90
26.94
27.00
27.07
27.33
27.43
27.48
27.56
27.56
27.72
27.72
27.93
27.93
27.93
27.99
28.09
28.09
28.19
28.33
28.51
28.88
29.03
29.16
29.20
29.50
29.73
29.81
29.92
29.92
30.08
30.08
30.22
30.54
30.75
30.90

Table 2.1 (continued)
Compound
RT (min)
182
N1-Acetylspermine
31.18
183
2Beta-hydroxy-1beta,(4A)beta-dimethyl31.24
7beta-(1-methyl-1-hydroxyethyl)-(8A)betadecahydronapthalene
184
Octane, 2,6-dimethyl31.42
185
Tridecane
31.64
186
2-Bromo dodecane
32.06
187
1,4-Methanonaphthalene-5,8-diol, 1,2,3,432.46
tetrahydro188
Carbonic acid, allyl 3-methylphenyl ester
32.46
189
Heptylcyclohexane
32.58
190
4-Hexen-1-ol, 5-methyl-2-(132.58
methylethenyl)-, acetate
191
Dihydrothymine
32.75
192
Heptadecane
32.83
193
3,9-Dodecadiyne
32.83
194
4-Methyl-1,3-dioxolane-2-one
33.04
195
(+)-Alpha-muurolene
33.04
196
Eremophilene
33.33
197
1-Propene, 1-bromo33.39
198
2,8-Decadiyne
33.45
199
6-Methyl-2-heptyne
33.48
200
(7Z,11Z)-7,11-Hexadecadienol
33.48
201
Arachidonic acid
33.58
202
Longifolene
33.63
203
Benzene, 1,2-diethyl33.73
204
Beta-farnesene
34.15
205
(S)-(-)-(4-Isopropenyl-134.48
cyclohexenyl)methanol
* level 1 identified compounds, and level 2 identified compounds that have p-value < 0.05 from
the Mann Whitney test are displayed in this table.

43

Figure 2.3

a: OPLS-DA plot for soft rot disease VOC samples (red triangles) and control
VOC samples (green circles) used in this study (R2X (cum) = 0.302, R2Y (cum) =
0.978, Q2 (cum) = 0.941, N = 96) b: S-plot of the OPLS-DA model with important
features

The points displayed in the PCA score plot represent a sample, and the distance between the points
shows the similarity between the samples. b: The S plot of the OPLS-DA model shows the
potential marker metabolites. In OPLS-DA score plots, each point represents a sample, and the
distance between points is related to the similarity between the samples. In the s-plot, each
triangle represents a feature/metabolite. The features which contribute more to the discrimination
of the disease group from the control group are in the upper right corner of the plot. OPLS-DA
model summary displayed in Figure A.3.
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Table 2.2

Discrimination features identified from the OPLS-DA model (disease vs control)
Level of

Compound ID

Rt (min) p(corr)

VIP
identification

Ethyl alcohol

4.81

0.836

1.663

1

1-Propanol

6.29

0.859

1.663

1

Ethyl Acetate

7.69

0.739

1.663

1

Butane, 2,3-dimethyl-

8.03

0.693

1.663

2

Ethyl propionate

11.17

0.722

1.663

1

3-Buten-ol,3-methyl-

12.07

0.649

1.663

1

Allyl isovalerate

12.49

0.773

1.663

2

Prenol

14.29

0.517

1.663

1

1,3-Pentadiene, 2,4-dimethyl-

15.21

0.719

1.663

2

Cyclopentane, methyl-

17.6

0.688

1.663

2

Ethyl crotonate

17.77

0.583

1.663

1

Ethyl isovalerate

18.54

0.639

1.527

1

Anisole

21.88

0.506

1.663

1

Butanoic acid, 3-hydroxy-, ethyl
22.31
0.737
1.663
2
ester
Metabolites identified from the disease group compared to the control group using OPLS-DA
model 1 (control vs. disease). The important features were selected based on > VIP 1.5 and p
corr > 0.5. Level of identification: 1 = verified with authentic compounds, 2 = identified with
data bases
2.3.3

Significant metabolites associated with time course fungal soft tissues disease
propagation
The disease progressed gradually with incubation time (Table A.1), and the time

course/kinetics of the significant metabolites (from OPLS-DA) was studied with results shown in
Figure 2.4 (additional metabolites demonstrated in Figure A.2). Some biomarkers (ethyl alcohol,
1-propanol, prenol, and ethyl propionate) were emitted during the initial stages of the disease.
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Prenol and 1-propanol emissions increased during the mid-stage of the disease propagation, and
some chemicals like ethyl crotonate, 1,3-pentadiene, and ethyl isovalerate became more prominent
during the later stages of the disease progression. Some of this volatiles had proved the antifungal
activity, such as anisole82, prenol, isoprenols82, ethyl propionate, and ethyl crotonate.83

Figure 2.4

The time course (from day 1 to day 28) emission of discriminating features
obtained from the OPLS-DA model (control vs disease). The y- axis is the sumnormalized peak areas of discriminating features. Control potatoes emission is
indicated by the letter c.
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Figure 2.4 (continued) The time course (from day 1 to day 28) emission of discriminating
features obtained from the OPLS-DA model (control vs disease). The y- axis is the sumnormalized peak areas of discriminating features. Control potatoes emission is indicated by the
letter c.
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Figure 2.5

Overlaid total ion chromatogram (TIC) of diseased and healthy sweet potatoes to
show the differences of emitted VOCs.

1: Ethyl alcohol, 2: 1-Propanol, 3: Ethyl acetate, 4: Ethyl propionate, 5: 3-methyl-3-buten-1-ol,
6: Prenol, 7: Ethyl crotonate, 8: Ethyl isovalerate, 9: Anisole, 10: l-Menthone
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2.3.4

Identification of metabolites associated with the early stage of sweet potatoes
fungal soft tissue disease
All the level 1 identified VOCs that are highly important for the diseased and healthy group

separation are displayed in the TICs in Figure 2.5. The goal of this study is the early-stage
diagnosis of sweet potato fungal soft tissue disease, leading to a minimization of post-harvest loss
due to R. stolonifer fungus in storage. Therefore, it is important to discover if there is a
discriminating pattern associated with volatile marker metabolites emissions that could be
monitored to track disease progression. In this study, three stages of R. stolonifer fungal disease
propagation on the sweet potatoes were identified. Namely, Stage 1 or early stage (initiation of
hyphal growth and the development of soft tissues), Stage 2 (prominent hyphal growth, soft
tissues,) and Stage 3 (deterioration of the tissues, sporulation, and wrinkling of the sweet potatoes).
Disease progression observation can be found in Table A.1 To minimize the complexity of the
analysis and maximize efficacy, our focus was on the early stage 1 disease diagnosis. To discover
potential biomarkers for the early diagnosis of the Rhizopus soft tissue disease, volatile chemicals
collected during Stage 1 propagation were compared with the control group. There were 21 early
disease symptoms showing samples (stage 1), and 45 control samples were used to build the
OPLS-DA model (Figure 2.6). The significant features responsible for distinguishing the stage 1
group from the control group are listed in table2. 2. (VIP > 1.5 and P corr > 0.5).
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Figure 2.6

a: The OPLS-DA score plot of control and stage 1 disease groups, b: The S-plot of
the OPLS-DA model with important features

The OPLS-DA score plot of control and stage 1 disease groups showed clear group separation.
The control group is green color circles, and the disease group is yellow triangles. (R2X (cum) =
0.239, R2Y (cum) = 0.991, Q2 (cum) = 0.944, N = 68) b: The S plot of the OPLS-DA model,
which shows potential marker metabolites. In OPLS-DA score plots, each point represents a
sample and distance between the points indicating the similarity between the samples where each
triangle represents a feature/metabolite. The features which contribute more to discrimination of
the disease group from the control group are in the upper right corner of the plot. PCA score plot
of the control vs. stage 1 displayed in Figure A.4, and OPLS-DA model summary displayed in
Figure A.5.
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Table 2.3

Features identified from the OPLS-DA (control vs. stage 1) for the early disease
diagnosis
Level of

Compound ID

Rt (min)

p(corr)

VIP
identification

3-Buten-ol,3-methyl-

12.07

0.6077

2.467

1

Ethyl propionate

11.17

0.6869

2.413

1

3-Hydroxypyridine
monoacetate

28.88

0.7622

2.279

2

Sorbic acid vinyl ester

22.99

0.7738

2.154

2

Fenchone

28.09

0.8809

1.875

2

l-Menthone

26.86

0.7748

1.855

1

Benzaldehyde, 4-(1methylethyl)-

30.08

0.7558

1.837

2

Prenol

14.29

0.5253

1.733

1

3,3Dimethoxypropiophenone

21.88

0.5825

1.691

2

Ethyl alcohol

4.81

0.7457

1.684

1

Bis(2-furfuryl) disulfide

11.61

0.5168

1.643

2

1-Propanol

6.29

0.7846

1.639

1

Cyclopentane, methyl-

17.60

0.5238

1.568

2

Benzaldehyde, 2,5-dimethyl- 28.19

0.5938

1.565

2

Meta-ethylphenol

33.52

0.6066

1.555

2

Allyl 2,4-hexadienoate

29.03

0.6753

1.545

2

trans,trans-3,5-Heptadien-214.92
0.6257 1.525
2
one
Metabolites identified from the stage 1 disease group when compared to the control group using
OPLS-DA model 1 (control vs stage 1). The important features were selected using VIP > 1.5
and p corr > 0.5. Level of identification: 1 = verified with authentic compounds, 2 = identified
using data bases.
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2.3.5

Biomarkers of the fungal soft tissue disease
The confirmation and validation of the significant features obtained from the OPLS-DA

models were further analyzed using receiver operating characteristic (ROC) curve analysis. The
performance of the individual biomarkers (Level 1 identified) was obtained with univariate ROCbased analysis is listed in Table 2.4. The univariate ROC results for all other putative biomarkers
are listed in Table A.3. Multivariate ROC curve-based exploratory analysis was used to evaluate
the predictive performance of the combination of the biomarkers obtained from OPLS-DA models
(Figure 2.7).84 The area under the ROC curve (AUC-ROC) is a standard method to express the
prediction accuracy of a single or combination of biomarkers for disease diagnosis.85 The putative
biomarkers, predictive power based on AUC-ROC, and their significance (p-value) can be found
in Table 2.4.
Table 2.4

The suggested biomarkers for the early diagnosis of the fungal soft rot disease

Metabolite

RT(min) AUC* P-value**

OPLS-DA Model***

1-Propanol

6.29

0.980

3.26E-03

1 and 2

Ethyl alcohol

4.81

0.980

3.17E-05

1 and 2

11.17

0.9341 8.02E-11

1 and 2

12.07

0.910

1 and 2

Ethyl
propionate
3-Buten-ol,32.34E-02

methyl* AUC of ROC analysis,** P-value from univariate analysis (t-test), *** 1 = control vs stage 1
and 2 = control vs disease
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Figure 2.7

Multivariate exploratory ROC analysis to evaluate biomarker combinations for
disease diagnosis.

a: ROC curve for biomarker combinations for fungal soft rot disease progression at all stages. 7.
b: ROC curve for biomarker combinations for early-stage diagnosis of the fungal soft rot disease.
Var: number of variables (biomarkers) used to build the model, AUC: area under the ROC, CI:
confidence interval.

Balanced sub-sampling Monte-Carlo cross validation (MCCV) was used to generate ROC
curves based on partial least squares discriminant analysis (PLS-DA) (www.metaboanalyst.ca).
Two-thirds of the samples were used for feature importance evaluation, and the top features were
used for the construction of the classification models. The other one-third of the samples were used
for validation of the classification models.
As a verification of the putative biomarkers for fungal soft tissue disease, additional spectra
were collected from the sweet potatoes stored in a simulated warehouse environment. Some of the
features selected from the OPLS-DA models were also observed in this simulated warehouse,
including of the selected important biomarkers (AUC > 0.9 and p-value < 0.05) (Figure 2.8). As
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mentioned above in section 2.3, control boxes were used in the warehouse environment simulation
with fungal-infected sweet potatoes. Surprisingly, the same putative disease biomarkers
discovered from the in-situ experiment were also found when keeping the healthy control sweet
potatoes in the warehouse near the infected boxes. Even when asymptomatic, the volatile chemical
profile became altered, indicating the presence of disease. It is possible that airborne R. stolonifer
spores from the infected sweet potatoes infected the control sweet potatoes. The fungal
contamination on control potatoes was confirmed by culturing control sweet potatoes tissues on
the PDA plates.

Figure 2.8

Box and whisker plots of selected high-performance biomarkers emitted from
sweet potatoes during warehouse storage 5 d after inoculation

The y- axis shows the sum-normalized peak areas of selected biomarkers.
Control: warehouse control samples, Disease: infected warehouse samples at 5 d after the
inoculation.

54

There were 2 OPLS-DA models created to study the VOCs emission of R. stolonifer fungal
infected sweet potatoes comparatively with control sweet potatoes. One OPLS-DA model (control
vs. disease) selected the marker compounds for fungal soft rot disease, and the other selected
marker compounds for the early diagnosis of the disease. The necessity of the second model came
with the observed time course effect among the selected features from the first OPLS-DA model
(control vs. disease). Both models showed high predictability (Q2 > 90%). 14 marker compounds
were identified that can be used to discriminate control from diseased sweet potatoes (Table 2.2)
and 17 marker compounds for the discrimination of stage 1 or early-stage disease sweet potatoes
from the controls (Table 2.3).
Four important biomarkers selected from the AUC of ROC analysis (AUC > 0.9) for the
fungal soft tissue disease were present in both models (control vs. disease and control vs. stage 1
disease). Therefore, it can be concluded that these biomarkers can be used to diagnose R. stolonifer
fungal rot disease in sweet potatoes at any disease progression stage. 1-Propanol is one of the
putative biomarkers with the highest performance (AUC > 0.9). 1-Propanol can be produced from
the precursor of 2-ketobutyrate, which could be produced in the threonine, pyruvate, or the Lhomoserine pathways of the R. stolonifer fungus.86 The presence of high levels of 1-propanol, and
ethanol in the volatile metabolome of soft rot diseased onions have been reported previously.69
Excess ethanol synthesis has been identified in most plant disease-associated VOCs. 70,71,77 Ethanol
can be formed because the pathogen stresses or damages tissues producing fermentation enzymes
such as alcohol dehydrogenase when the no or low oxygen levels are present in the cells. 87,88 It is
well known that soft rot diseased sweet potatoes smell fruity. Ester compounds such as ethyl
acetate, and ethyl isovalerate might be responsible for that fruity odor. 3-Buten-ol, 3-methyl
(isoprenol), a hemiterpene alcohol, is another high-performed marker compound. It is produced
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by S. cerevisiae (zygomycotina) using the mevalonate pathway.89 According to the literature,
isoprenol can produce from either mevalonate (MVA) or 2-C-methyl-d-erythritol-4-phosphate
(MEP) pathways.90 Prenoid molecules such as prenol and isoprenol are precursors for terpenoids.
In this study, mono-terpenoids, geraniol and nerol, were part of the collected and identified volatile
organic compound profile. Therefore, we can conclude that the prenoid alcohols are highly active
during disease propagation of the fungal soft rot tissues. All results indicate that identifying
specific chemicals related to species could be a foundation for metabolic engineers to elucidate
biosynthesis pathways. Kim et al. illustrated that the presence of high sugar content and amino
acids in the sweet potatoes could lead to high alcohol production during fungal disease
propagation, leading to increased production of ethyl esters as a response.87 Our results show the
presence of the ethyl propionate at the early stage of the fungal soft tissue disease and that emission
increased throughout the disease propagation from the early stage to the later stage, as illustrated
in Figure 2.7.
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Scheme 2.1

Proposed biosynthesized pathways associated with the R. stolonifera soft rot
disease, underlined compounds were detected with this HS-SPME GC-MS
platform, and dash lines represent chains in the mechanisms

Results allow us to propose a biosynthesis pathway activated during soft rot disease
propagation (Scheme 2.1). 1-Propanol has been detected in the mixtures of biofuels via acetonebutanol-ethanol fermentation.91 Identification of propanol biosynthesis from fungal soft rot disease
might elucidate aspects of the biofuel synthesis industry.
Most of the identified volatile compounds used for discrimination (OPLS-DA) have been
noted in previous literature associated with Rhizopus oryzae (Mucoromycota) VOC emissions.
They are ethanol, ethyl acetate, 1-propanol, and ethyl propionate88. Ethyl acetate is also
synthesized in fungal cells by using acetyl CoA and ethanol with the alcohol catalysis
acyltransferase89. Ethyl crotonate is produced from the esterification of the isocrotonoic acid and
ethanol. This phenomenon highlights the excessive production of ethanol during disease
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progression. Ethyl propionate has also been identified from the analysis of VOCs from fungal
cultures of Muscodor albus, and its presence can be used for post-harvest disease control in
apples90. The fungal culture analysis showed that most of the VOCs specifically generated by the
R. stolonifer fungi are butane derived chemicals, such as 3-methyl-2-butanone, 2-butanone, 3buten-1-ol, 3-methyl, 2-methyl-1-butanol, and ethyl isobutyrate (Table A.5 and Figure A.6, and
A.7).
In conclusion, this HS-SPME GC-MS untargeted metabolomics work identified a set of
volatile metabolites related to the progression of fungal soft tissue disease on sweet potatoes,
especially while in storage conditions. The OPLS-DA model identified ethyl acetate ethyl
crotonate, ethyl isovalerate, and anisole as specific for the later stage of the disease, while 1menthone emissions were associated with the early stages of the disease. Ethyl alcohol, 1propanol, 3-methyl, 3-buten-1-ol, prenol and ethyl propionate were present in the volatile profile
of both of early and later stages of the disease. Therefore, based on our observations, we
hypothesized that the synthesis of high ethanol content in the fungal-infected sweet potatoes could
lead to more VOCs, especially ethyl acetate, ethyl crotonoate and isoprenol, being produced. Even
though many discriminatory biomarkers were identified, only the above 10 were confirmed as
level 1 identified metabolites. OPLS-DA combined with ROC analysis identified 1-propanol, ethyl
alcohol, 3-methyl, 3-buten-1-ol and ethyl propionate as putative volatile disease markers for the
fungal soft tissue disease in sweet potatoes. Additionally, we found that the Rhizopus stolonifer
fungi emitted much butane-derived volatiles, including ketones, alcohols, and esters. Overall, these
findings elucidate the volatiles associated with the growth of Rhizopus stolonifer on sweet
potatoes. Future goals would be to develop a sensory device to detect all or some of the putative
biomarkers in a commercial storage setting.
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CHAPTER III
EVALUATION OF EXTRACTION METHODOLOGIES FOR FUNGI: MACROPHOMINA
PHASEOLINA AND CHARACTERISTIC VOLATILE AND NON-VOLATILE
METABOLITES FOR DISCRIMINATING FLAT
AND FLUFFY MORPHOLOGIES
3.1

Introduction
M. Phaseolina is a soil-borne pathogenic fungus known worldwide for its ability to infect

over 500 plant species in over 100 families.92,93 It is a known cause of diseases such as charcoal
rot, stem rot, root rot, and seedling blight and affects several host crops plants such as cotton,
soybeans, common bean, mung bean, potato, and sorghum.92,94–96 The morphology of M.
Phaseolina can vary based on the substrate or isolates, but commonly will appear light brown in
early stages and will darken into black as it ages .93,97 M. Phaseolina can be found in a variety of
climates, including arid and tropical, but tends to cause the most devastation in dry (soil moisture
below 60%), and hot (30-35 ⁰C) regions.93,95 M. Phaseolina infected crops have significant yield
losses. For example, the United States annually loses over 1000 metric tons of crops due to the
impact of M. Phaseolina.92 M. Phaseolina has a microsclerotia microstructure and can survive
either in soil or infected plant debris anywhere from 2-15 years based on the climate conditions.97
It can then infect the host plant’s roots during the seedling stage with multiple germinating hyphae.
The fungus then interferes with the transportation of water and nutrients throughout the host
plant.93 The fungus will secret pectinase, xylanases, cellulases, and proteases to depolymerize cell
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wall components like cellulose xylem, pectin, and other proteins. It will also produce lipases to
cause the hydrolysis of mono and diglycerides into free fatty acids and toxins, such as
phaseoloinone, to facilitate infection.97 Once infected, host plants will show symptoms such as
yellowing leaves, sloughing tissues around the lower stem and taproot, and dark lesions on the
stem as the plant begins to defoliate and wilt.93,98 Eventually, the tissues on the host plant will turn
grey due to the formation of new microsclerotia.93 When the plant dies, these microsclerotia will
be released back into the soil.93,94
In the field of metabolomics, a metabolome is a term used to describe the complete set of
low molecular weight metabolites (< 1500 Da) existing in a biological sample.2,12 In recent years,
Gas Chromatography-Mass Spectrometry (GC-MS) has become a routine method of analyzing
metabolomes in the study of plants.12,99 This is partly due to its low cost compared to other MSbased analytical methods, its reliable chromatographic reproducibility and resolution, its ability to
repeat mass fragmentation through Electron Impact ionization (EI), and its few matrix effects.99
However, this method is not perfect as it requires that the analyzed compounds be volatile as-is or
be modified into volatile compounds through derivatization.99 Any non-volatile compounds won’t
be observed through GC-MS. The goal of this study is to differentiate the two prominent
morphologies of the MP fungi using their volatile and derivatized-volatile metabolome. The aim
was to cover more metabolites present in the MP fungi by analyzing both volatile and non-volatile
metabolites using two different GC-MS workflows.2
When preparing a sample for metabolite liquid extraction, it is important to note that
metabolites cover a wide range of compounds.12,99,100 These compounds include nucleic and amino
acids, carbohydrates, peptides, vitamins, and alkaloids.2 Due to the diversity in the chemical
properties of the compounds, there is no single solvent that can be used to extract all metabolites
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effectively.100 Several extraction solutions are used to effectively extract a single target metabolite
or a class of metabolites. Hydrophilic metabolites can be extracted with mixtures of a polar organic
solvent, such as methanol or ethanol, and water or use of perchloric acid, which can also be used
to precipitate proteins from the sample. Hydrophobic metabolites can be extracted with more nonpolar solvents like chloroform or methyl-tert-butyl ether
Volatile organic compounds (VOCs) are carbon-based compounds of low molecular
weight (< 300 Da) that can enter the gaseous phase near 20 ⁰C at 0.01 kPa.4,45,101–106 Microbial
VOCs are separate compounds produced during primary and secondary metabolism from life
forms, including soil-borne microbes such as bacteria and fungi.102,107–109 MVOCs can form
complex chemical mixtures containing alcohols, ketones, aldehydes, alkenes, thiols, esters,
benzenoids, terpenes, and pyrazines.101,103,104,109 These compounds can diffuse quickly through the
atmosphere and soil, allowing them to act as signaling chemicals.106,109 However, variations of
these mixtures can be produced in a given species or strain based on environmental
conditions.102,107,109–111 Variable conditions include nutrients, temperature, soil pH, available
oxygen, soil moisture, and the microbe’s growth stage.101,105,110 As VOCs result from metabolism,
it is essential to study the physical conditions that can affect metabolite production, such as the
anatomical, morphological, and physiological development unique to each fungus.102,109,112
Recent agricultural research has focused on the diversity and potential functions of
MVOCs and their roles as semiochemicals among bacteria, fungi, and plants.102,105 Many studies
have shown that MVOC interactions can positively impact plant growth, including promoting
inhibition or resistance to plant pathogens and affecting plant secondary metabolite production
.102,105,109,113 These studies mainly focus on the VOCs produced by endophytic fungi belonging to
Trichoderma,

Chaetomium,

Piriformospora,
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Curvularia,

Fusarium,

Epicoccum,

and

Penicillium.102,104,113 Most studies into MVOCs have investigated the beneficial properties
between the plants and microbes, while a few have investigated the impact on plant development
caused by MVOCs produced by plant pathogenic microbes.101,106,113 These studies speculate that
the VOCs produced by these pathogens interact with the processes involved in plant growth,
development, and defense.105 Investigated pathogenic bacteria such as Burkholderia,
Pseudomonas, and Stenotrophomonas have been shown to produce several VOCs that suppress
host defense responses, inhibit plant growth, and exhibit phytotoxicity.106
3.2
3.2.1

Materials and Method
Chemicals and culture media
Butanol (HPLC grade, Sigma-Aldrich), methanol, water, and acetonitrile, and isopropyl

alcohol in optima grade (Sigma-Aldrich) Pierce™ BCA Protein Assay Kit (Thermo Fisher
Scientific), O-methoxyamine hydrochloride, N-methyl-N-trimethylsilyl trifluoroacetamide
(MSTFA) (Sigma Aldrich), pyridine anhydrous (Sigma Aldrich), 2-chloro-phenyl alanine (Alfa
Aesar), and PDA media (Fisher Scientific) were purchase commercially and used as received.
MP fungal strains (MP-60, MP-65, MP-85, MP-120, MP-174, MP-180, MP-205, MP-214,
MP-216, MP-253, MP-277, MP-304, MP-215) were obtained from Dr. Richard Baird’s
(Department of Biochemistry, Molecular Biology, Entomology, and Plant Pathology, Mississippi
State University) fungal culture collection which is stored at -80 °C. Fungal cultures were grown
in potato dextrose agar (PDA) media and were sub-cultured every two weeks to maintain the
viability of the fungi.
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3.2.2
3.2.2.1

Non-volatile metabolome GC-MS
Liquid cultures of MP fungi
MP fungi grown in liquid media were used to examine the non-volatile metabolome. An

MP fungal plug (3 mm diameter), subcultured on PDA media, was added to basal liquid media (50
mL in a 150 mL conical flask), capped with aluminum foil, and sealed with parafilm. Cultures
were grown for seven days at 37 °C in an incubator. After seven days, fungal hyphae were
harvested and extracted according to section 3.2.2.2.
3.2.2.2

MP solvent extraction optimization
MP strain 215 was used as the model strain to establish the solvent extraction protocol for

the MP fungal metabolites. MP-215 was grown in liquid basal media for 7 d as described in section
3.2.2.1. Fungal hyphae were harvested with vacuum fast filtration, flash frozen in liquid nitrogen
and crushed into a fine powder using a pre-cool mortar and pestle. There were six different
extraction solvent systems tested for intracellular metabolites extraction of MP fungi: Ex 1=
methanol : water (4:1, v/v) at -20 °C, Ex 2 = IPA 100% at -20 °C, Ex 3= acetonitrile: water (1:1,
v/v) at -20 °C, Ex 4 = butanol: methanol (1:1, v/v) at -20 °C, Ex 5= butanol: ethanol: water (2:1:1,
v/v) at -20 °C, Ex 6 = butanol: methanol: water (2:1:1,v/v) at -20 °C.
Ground MP hyphae 0.1 g was weighed to a pre-cool Eppendorf tube, and 20 µL of 2chloro-phenyl alanine (1 mg/1 mL in 50% methanol) was added as an Internal Standard (IS). Then
0.5 mL of extraction solution was added and vortexed for 60 s and kept at -20 °C for 60 min to
allow the protein to precipitate to the bottom of the Eppendorf tube. Eppendorf tubes were then
centrifuged at 14000 g for 15 min at 4 °C. Next, 100 µL of the supernatant was pipetted to a precooled Eppendorf tube, and the solvent was completely removed in a lyophilizer. The dried crude
was derivatized using a method described by Dunn et al. with some modifications.114 Briefly, 50
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µL of O-methoxyamine hydrochloride (20 mg/1 mL in pyridine) was added to the dried
metabolites in the Eppendorf tube, vortexed for the 30 s, and incubated at 80 °C for 15 min. Then
50 µL of N-methyl-N-trimethylsilyl trifluoroacetamide (MSTFA) was added to the Eppendorf
tube, vortexed for the 30 s, and again incubated for 15 min at 80 °C. After the incubation period,
Eppendorf tubes were cooled to room temperature and, 20 µL of retention index mix (docosane,
nonadecane, pentadecane decane, and dodecane) was added before being vortexed for the 30 s. 85
µL of the derivatized mix was added to the glass insert (200 µL), which was inserted into an amber
color autosampler vial (2 mL) and closed with a cap equipped with a septum. Each extraction
method was repeated five times using five different technical replicates of the same biological
species.
The derivatized metabolites were subjected to GC-MS analysis using a Shimadzu (Tokyo,
Japan) (GC-2010 with QP-2010) equipped with an auto-sampler (AOC-20i+s). The injection
volume was set at 1 µL, and the injector temperature was set at 250 °C in the spitless injection
mode. Derivatized metabolites were separated in an Rtx-5 ms (Restek, Bellefonte, PA, USA)
column (30 m × 0.25 mm × 0.25 µm, length × inner diameter × film thickness, respectively). UHP
helium was used as the carrier gas at the flow rate of 1 mL/min. GC temperature program is set as
below. Initially, column temperature was set at 40 °C for 3 min, then ramped to 250 °C at the
heating rate of 20 °C/min, and held for 2 min, then again, the temperature was ramped to 280 °C
at the heating rate of 25 °C/min and held for 3 min. For MS detection, EI ionization was done at
70 eV, ion source temperature was set at 240 °C, and full scan acquisition was obtained over the
35-600 m/z range.
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3.2.2.2.1

Protein quantification

Protein in the cell pellet and the supernatant of the extraction solutions were quantified (at
A 562 nm) using a BCA protein assay kit (Pierce ™ BCA protein assay kit, ThermoScientific).
100 µL of the supernatant was subjected to BCA analysis as per manufacturer guidelines to
determine the protein content in the solution phase using UV-VIS spectrophotometry. Lyophilized
cell pellets were ground using a mini bead beater with 100 mg of beads (0.5 mm, Zirconia-silicate)
and 150 µL of protein extraction buffer (100 mM Tris HCl (pH 8), 1 mM EDTA, 150 mM NaCl,
and 1% Triton x) was added, vortexed vigorously, and incubated on ice for 15 min. Vortexing and
incubation were repeated twice and centrifuged at max speed for 5 min. The cell lysate was
transferred to Eppendorf tubes and stored at -20 °C for analysis.
Protein precipitation efficiency =

Solution phase protein content
Total protein content

× 100%

(3.1)

The total protein content is the cumulative proteins content of the solution and solid phase
(cell pellet).
3.2.3

Volatile metabolite extraction from solid cultures of MP
MP fungi grown on solid basal media were used to examine its volatile metabolome. Basal

media (15 mL) was added to a 40 mL glass vial. MP fungal plugs (3 mm) from the subculture PDA
plates were added to the vial and sealed with a septum. Fungal cultures were grown for seven days
at 37 °C in an incubator.
3.2.3.1

Headspace solid-phase microextraction (HS-SPME) of microbial volatile
organic compounds (MVOC) of MP fungi
Commercially available carboxen/polydimethylsiloxane (CAR/PDMS) SPME fibers were

used to extract and concentrate the evolved MVOCs of the fungal cultures. This fiber type was
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used based on previous fungal experiments done at our lab.18 The SPME fiber was inserted into
the fungal vial by piercing the septum and then exposed for 30 mins to the headspace of the fungal
culture to extract the MVOCs. After 30 min, the SPME fiber was inserted into the GC-MS, and
the collected MVOCs were subjected to GCMS analysis. Extraction blanks were carried out using
a basal media glass vial with a non-inoculated PDA plug.
3.2.3.2

Quality control sample preparation
MP fungi-215 was used to infect a sweet potato; at seven d, the infected tissues were flash-

frozen in liquid nitrogen and crushed into a fine powder. The ground fungal infected tissues (20 g)
were placed into water (20 mL) to extract soluble compounds before being centrifuged at 3000
rpm. 200 µL of the supernatant was transferred into 1 mL GC-MS vials and stored at -20 °C. These
-20 °C stored vials were intermittently subjected to HS-SPME and analyzed throughout the
experiment.
3.2.3.3

Volatile metabolome GC-MS analysis
MVOC extracted with SPME fibers were separated using a GC (7890A; Agilent

Technologies, Santa Clara, CA, USA) equipped with a DB-1 (dimethylsiloxane) capillary column
(60 m × 0.32 mm × 1 µm, length × inner diameter × film thickness, respectively) and detected with
MS (5975C, Agilent technologies). The SPME fiber was desorbed for 5 min in spitless mode at
270 °C in the inlet port of the GC-MS. The injector port was operated in the split–spitless mode
for 2 min. Thermal desorption of the SPME fiber was carried out for 5 min to eliminate all possible
carryovers for future extractions. Ultra-high purity He was used as the carrier gas at the flow rate
of 1 mL/min. The GC-MS oven was programmed at 45 °C for 2 min before ramping to 150 °C at
a heating rate of 15 °C/min, again the temperature ramped to 230 °C at the heating rate of 5 °C/min.
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Finally, the temperature ramped to 270 °C and was held for 3 min. Separated VOCs were subjected
to MS detection with EI ionization. The ion source temperature was set to 230 °C, and the
quadrupole temperature was set to 150 °C. Full scan spectra were acquired in the 35-350 m/z range.
3.2.4

GC-MS data preprocessing annotation
Raw GC-MS data files for the volatile and non-volatile metabolites were converted into

the NetCDF format using Agilent chemstation and Shimatzu post-run analysis software,
respectively. Spectral deconvolution, automated peak detection, peak picking, and alignment were
done using the web-based spectral data post-processing platform: GNPS with default settings.
(https://gnps.ucsd.edu/) 81 GC-MS peak annotation was carried out in the same platform (GNPS,
Library search, and networking) by searching public libraries.81
3.2.5

Data analysis
RT aligned data matrix was used for the data analysis. Initial group separation was done

with the Mann Whitney U test performed in SPSS Statistics 26 for Windows (SPSS Inc., Chicago,
IL, USA). Features that have a p-value < 0.1 were subjected to the multivariate data analysis. Data
were normalized by sum, log-transformed, and auto-scaled before the multivariate analysis.
Principle component analysis (PCA), Partial least square discrimination analysis (PLS-DA),
Hierarchical cluster analysis (HCA), Orthogonal partial least squares discrimination analysis
(OPLS-DA), and pathway enrichment analysis were performed using the MetaboAnalyst platform.
(https://www.metaboanalyst.ca)80
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3.3

Results and Discussion

3.3.1

Metabolite extraction solvent optimization
The extraction performance of the six solvent mixtures was evaluated to extract MP fungal

metabolites using the relative abundance and the consistency of the results. Extracted metabolites
were analyzed using a GC-MS-based untargeted metabolomics pipeline followed by a TMS
derivatization. First, the robustness of the analytical platform was evaluated by plotting the pooled
QC samples with the test samples. As shown in Figure 3.1, all the QC samples are grouped
together, and the data generated from the untargeted pipeline was subjected to the downstream
analysis.
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Figure 3.1

A: PCA score plot with QC samples and all test samples to evaluate the reliability
of the analytical platform
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Figure 3.1 (continued) B: PLS-DA score plot of all samples to show group differentiation
Ex 1 = methanol: water (4:1, v/v) at -20 °C, Ex 2 = IPA 100% at -20 °C, Ex 3 = acetonitrile:
water (1:1, v/v) at-20 °C, Ex 4= butanol: methanol (1:1, v/v) at -20 °C, Ex 5 = butanol: ethanol:
water (2:1:1, v/v) at -20 °C, Ex 6 = butanol: methanol: water (2:1:1, v/v) at -20 °C.
Ex = Extraction mixtures.
3.3.1.1

Evaluation of the consistency and the metabolome coverage of the solvent
mixtures
The coefficient of variation (CV) or relative standard deviation, as shown in equation 3.2,

was used to determine the consistency and the reproducibility of the extractions of the six
different solvent mixtures in the GC-MS platform.
Standard deviation
× 100%
mean
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𝐶𝑜𝑒𝑓𝑓𝑖𝑐𝑖𝑒𝑛𝑡 𝑜𝑓 𝑣𝑎𝑟𝑖𝑎𝑡𝑖𝑜𝑛 (𝑐𝑣)% =

(3.2)

The average CV% (peak intensity of all detected compounds) of the six different solvent
mixtures are: Ex 1 = 81.32, Ex 2 =106.32, Ex 3 = 81.4, Ex 4 = 99.21, Ex 5 = 83.9 and Ex 6 =
68.41. Even though the average CV% (total metabolites intensities) values are high, many
extracted individual metabolites have a CV% of less than 30. This high CV% is common in the
GC-MS-based workflows, especially when derivatization is coupled with GC-MS. Moreover, the
relatively short GC columns might promote a higher CV%.17 There was a sufficient CV% (peak
intensity of individual compound across the five replicates) (< 30%) in the detected individual
metabolites across the six solvent mixtures for continued analysis. For example, there was 87.88%
for Ex 1, 50.43% for Ex 2, 80.86% for Ex 3, 52.17% for Ex 4, 88.69% for Ex 5 and 86.92 for Ex.
6. The CV% for all detected metabolites are shown in the whisker and box plot in figure 3.2.

Figure 3.2

The whisker and box plot to show the CV% peak intensities of all detected
metabolites across the six solvent mixtures
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The metabolome coverage of the tested solvent systems was evaluated using prominent
metabolites present in a typical fungal cell lysate. These selected metabolites had a high tendency
to express differentially when metabolome perturbations occurred. Moreover, these selected
metabolites cover a wide range of chemical polarity. For example, as shown in figure 3.3, stearic
acid, palmitic acid, and oleic acid (lipid-like molecules) and L-aspartic, and L-arginine (polar
amino acids), and polar sugar molecules like glucose and fructose were selected. Polar amino acids
(mentioned above) to non-polar amino acids, such as L-alanine, were in the chosen metabolites
list. UDP-N-acetyl glucosamine was selected because it is an intermediate in the chitin
biosynthesis pathway. Chitin is the building block of the fungal cell wall. 115 L- Arginine and Lproline amino acid-associated biochemical pathways are very susceptible to metabolism
perturbations due to both abiotic and biotic stress on fungi or any physiological variations with the
fungal strains.116 Therefore, evaluation of the extractability of these chemicals is essential. In the
future, these results can be a foundation to initialize a targeted metabolomics approach and then
for absolute quantification of specific metabolites.
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Figure 3.3

Extractability of compounds in different chemical properties across the six
solvent systems
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Figure 3.3 (continued) Extractability of compounds in different chemical properties across the
six solvent systems
Hierarchical cluster analysis was performed for the highest abundance of extracted
metabolites in all extraction mixtures. The group average of the five replicates of each extraction
solvent mixture is shown in the heat map displayed in Figure 3.5. The 25 most abundant
metabolites are shown in Figure 3.4. Ex 6, which consisted of butanol: methanol: water (2:1:1,
v/v) had the highest extractability of the six solvent mixtures.
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Figure 3.4

Heat map showing the different extractability of the six solvent mixtures

Average abundance values are displayed in the above heatmap.
Ex 4 and Ex 3 were butanol:methanol (1:1, v/v) and butanol: ethanol:water (2:1:1, v/v)
respectively. The metabolite extractability of these two solvent mixtures was not as good as the
best (Ex 4), which consisted of butanol: methanol: water (2:1:1, v/v). The extraction ability of the
solvent mix: Ex 5 was the second-best. A comparatively good metabolite extraction ability was
associated with Ex 2, which consisted of 100% IPA. Good extraction was observed for 100% IPA
and BuME (butanol: methanol) for the lipidome and metabolome of human plasma in a single
extraction step.35 But, in this case, when addressing the filamentous fungus metabolome, these two
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reported extraction solvents did not perform well. The difference matrix associated with the two
types of biological samples likely affected extractability of the metabolome. There were 110
metabolites (Table B.1) detected in the GNPS database.
3.3.1.2

Protein precipitation evaluation
Protein-like giant molecules can impact mass spectrometry detection of the small

metabolite molecules. Even though membrane filtration can be used to remove proteins during
metabolite extraction, it might cause metabolite loss or add artifacts. Therefore, the best way to
address the protein issue is to develop an extraction solvent system that simultaneously precipitates
proteins. The ability to precipitate proteins while extracting the metabolites is considered one of
the advantages of an extraction solvent mixture. Protein precipitation of the extraction solvents
was determined using the BCA method. Figure 3.5 shows the protein precipitation ability of each
solvent, which shows a comparatively equal protein removal efficiency of the tested solvent
systems except for Ex 2, which had a reduced removal efficiency. The highest protein precipitation
was observed for the butanol: ethanol: water (2:1:1, v/v) mixture.
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Figure 3.5

Protein precipitation efficiency of tested six extraction solvents.

All considered (extraction consistency, metabolome coverage, and the protein precipitation
efficiency), the solvent system, Ex 6: butanol: methanol: water (2.1:1, v/v) was selected to further
study the MP fungal metabolome.
3.3.2

Untargeted metabolomics study to differentiate MP two morphologies
To broaden the coverage of the MP metabolome, the volatile metabolites and the non-

volatile metabolites were analyzed using two different GC-MS platforms (HS-SPME GC-MS and
derivatization followed GC-MS). Twelve strains of MP fungi were selected based on their
morphology/physical appearance. We observed there were two main differences in MP fungi when
it grew on PDA Petri plates. Some MP strains have a furry morphology and others appear to be
embossed. These were designated as either fluffy or flat MP, as shown in Figure 3.6.
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Figure 3.6

3.3.2.1

Photographs of MP: fluffy and flat strains (7 days old) on PDA plate to show
morphology differences.
Analyzing the volatile metabolome of the MP fungi

The HS-SPME technique extracted the volatile organic compounds accumulated in the
headspace of a solid MP strain culture. PDMS-CAR SPME fiber was chosen for sample collection
based on previous results. Typical TIC spectra generated from HS-SPME GC-MS analysis of MP
two different morphologies are shown in Figure 3.7 shows the VOC emission pattern of a typical
fluffy strain, and 3.8 B shows the VOC emission pattern of a typical flat strain. A total of 101
volatile metabolites evolving from MP flat and fluffy strains were identified and are listed in Table
B.3. MSI implements guidelines for metabolomics studies: had assigned four levels of compound
identification in the metabolomics.64 According to the MSI, the metabolites reporting in this study
are identified at level 2, which indicates that metabolites are identified by matching with spectral
databases. All the metabolites reported in this study had a match score above or equal to 80%.
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Figure 3.7

A: Total ion chromatogram of the volatile organic compound collected from the
headspace of a fluffy strain: MP-85 B: Total ion chromatogram of a flat strain,
MP-277.
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Figure 3.8

A: PCA score plot of the VOCs extracted from MP flat and fluffy strains and B:
OPLS-DA score plots for VOCs extracted from MP both strain morphologies R2X
= 0.0762 R2Y = 0.424 Q2 = 0.344

PC1 and PC2 of the PCA plot show 21.5% and 8.2% of variance, respectively, of the
variation between MP flat and fluffy morphological groups (Figure 3.8). Nearly 30% of the total
variance presents from the unsupervised PCA analysis. Supervised OPLS-DA was performed to
capture more variance in the data. The OPLS-DA score plot shows a clear separation of the flat
morphology group from the fluffy group. The OPLS-DA model was obtained using one
predictive component (p0) and three orthogonal components with R2X = 0.0762, R2Y = 0.424,
and Q2 = 0.344. Q2 gives the accuracy of the predictive model, and generally, 0.3 is the cutoff
value.1 This cutoff value is not a set value, but there is an agreement in the metabolomics or
clinical scientific community to use 0.3 as the cutoff. Therefore, the above OPLS-DA is
considered to be statistically justified for further analysis. Each metabolite responsible for
differentiation of the two morphologies was analyzed using variable importance in the project
values (VIP > 1) and Mann Whitney test p-values (< 0.05). Forty-four features were selected to
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discriminate the flat group from the fluffy group which had VIP > 1 and a p-value < 0.05. These
are listed in Table 3.1.

Table 3.1

Volatile metabolites responsible for the morphological differences of MP flat and
fluffy

Compound
Propyl Acetate
Monomethyl Glutaric Acid
Thiophene, Tetrahydro-2Methyl4,6-Dimethyl Pyrimidine
Octane
Pentanone (2-)
1-Heptanol
2(3H)-Furanone, 3Bromodihydro4-Pentyn-2-Ol
Butane, 1,1'-Oxybis[4-Chloro2-Isobutyl-3-Methylpyrazine
Octanol Acetate
2,4-Dimethyl-1-Heptene
2,5-Dimethylcyclohexanol
Tartaric Acid-Tetra-Tms
Ethyl Tetradecanoate
1,3-Di-Tert-Butylbenzene
Linalool
Undecanol
Pentane, 2,2,3,4-TetramethylPhenylethyl Acetate
2-Tridecanone
Citral
Pentane, 3,3-Dimethyl2-Methyl Imidazoline
N-Octadecane
Hepten-2-One (6-Methyl-5-)

VIP
2.099
1.941
1.845

p-value
6.519E-05
3.178E-06
5.914E-03

1.800
1.765
1.744
1.695
1.691

9.489E-06
7.757E-05
1.442E-04
1.327E-03
1.267E-03

1.648
1.647
1.632
1.604
1.599
1.597
1.586
1.570
1.487
1.473
1.462
1.393
1.365
1.362
1.356
1.352
1.334
1.314
1.314

9.743E-03
6.149E-05
1.032E-04
1.795E-04
2.335E-05
4.157E-04
1.999E-04
3.053E-04
3.566E-04
1.155E-03
1.011E-02
6.200E-04
5.042E-03
7.757E-05
1.822E-03
1.210E-03
3.787E-03
7.907E-04
3.204E-03
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Table 3.1 (continued)
Compound
Methoxy Acetic Acid
2,3-Dimethyl-2-Cyclopenten1-One
2-Tert-Butylcyclohexyl
Acetate
Benzaldehyde
Furan, 2,2'-Methylenebis[5MethylOctanol
Caryophyllene (Z2-Pyrrolidinone
2-Methoxyethanol
Dodecanol
Pentadecane
2-Hexanol
Nonane, 2,2,4,4,6,8,8HeptamethylOxalic Acid
Pentane
Dihydrothymine
Benzoic Acid

VIP
1.311
1.278

p-value
1.666E-03
1.016E-02

1.266

3.566E-04

1.243
1.237

1.130E-02
3.342E-03

1.236
1.200
1.159
1.116
1.095
1.094
1.050
1.034

2.820E-03
2.702E-03
1.742E-03
3.754E-04
1.306E-02
9.040E-03
8.705E-03
5.914E-03

1.013
0.966
0.946
0.934

1.002E-02
9.040E-03
3.342E-03
1.002E-02

VIP values obtained from the OPLS-DA model of non-volatile metabolites of flat vs. fluffy and
the P- values obtained from the Mann-Whitney U test.
3.3.2.2

Analyzing the non-volatile metabolome of the MP fungi
Non-volatile metabolome differentiation of the flat and fluffy morphologies was carried

out in the same way described above for the volatile metabolite differentiation using a different
GC-MS platform. Non-volatile metabolites were extracted using butanol: methanol: water (2:1:1,
v/v) solvent extraction mix, which had better performance than other solvent systems tested. In
addition, the non-volatile metabolites were derivatized before GC-MS analysis. Derivatization
enhances the volatility of the analytes, hence facilitates gas chromatographic analysis. The flat and
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fluffy morphologies were carried out using OPLS-DA models to maximize group separation, as
shown in Figure 3.9. The differentiation of volatile and non-volatile metabolites was carried out
using variable importance in the project values (VIP > 1) and Mann Whitney U test p-values (<
0.05) for each metabolite.

Figure 3.9

A: PCA score plot of the non-volatile/solvent extracted metabolites from MP flat
strains and fluffy strains and B: OPLS-DA score plots of MP flat and fluffy strains
R2X = 0.134, R2Y = 0.912, and Q2 = 0.864

PC1 and PC2 of the PCA plot explain 15.2% and 10.7 %, respectively, of the variation
between MP flat and fluffy morphological groups. This represents 25.9% of the total variance
presents from the unsupervised PCA analysis. Supervised OPLS-DA was performed to capture
more variance in the data. OPLS-DA score plot in Figure 3.10 B shows the clear separation of the
two groups: flat and fluffy. The OPLS-DA model was obtained using one predictive component
(p0) and two orthogonal components with R2X = 0.134, R2Y = 0.912, and Q2 = 0.864. Therefore,
83

the above OPLS-DA is statistically accurate to use for further analysis. The metabolites
responsible for the differentiation of the two morphologies were selected based on their VIP and
p-values. There were 52 (VIP > 1, p < 0.05) metabolites chosen to differentiate the two groups.
These differential metabolites are listed in Table 3.2.
Table 3.2

Non-volatile/Solvent extracted and TMS derivatized metabolites to differentiate
the two morphologies of the MP fungi

Compound
Methylmalonic Acid
2,4-Dinitroaniline
Methyl Octadecanoate
3,6-Dimethyl-1-Heptyn-3-Ol
3-Methylglutaric Acid Di-Tms
Thioinosine
N,N-Dipropylnitrosoamine
Dl-Alanyl-Dl-Methionine
1H-Purine, 2-MethylBromodiphenhydramine
2-Phenylpropanal Ethylene
Glycol Acetal
D-(+)-Glucose
5-Methyl-1,3Cyclohexanedione
Triethylene Glycol
2-Chloropropane
Levo-Menthoxyacetic Acid
Linoleic Acid
Acrylonitrile
Cephaloridine
L-Norleucine
Benzene, 1,1'-(1,3-Butadiyne1,4-Diyl)BisHexanoylglycine
2-Methylfuran
Melezitose

VIP
2.146
1.937
1.906
1.879
1.837
1.817
1.808
1.686
1.645
1.625
1.584

P-value
5.470E-08
2.250E-07
3.670E-05
4.440E-08
1.350E-03
1.250E-05
1.260E-06
2.740E-07
4.100E-06
6.530E-07
2.840E-04

1.572
1.547

4.040E-07
1.350E-09

1.525
1.525
1.428
1.414
1.392
1.384
1.350
1.335

1.040E-03
1.970E-03
3.330E-07
2.460E-03
2.660E-05
1.630E-03
1.840E-04
1.690E-09

1.317
1.299
1.298

2.620E-06
1.590E-04
8.680E-07
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Table 3.2 (continued)
Compound
Butanoic Acid, 2-Amino-4(Methylsulfinyl)-, (.+/-.)Methyl Tetradecanoate
2,5-Diethoxy-3-Methyl-3Vinylhexane
Monomethyl Glutaric Acid
2-Hexanol
Pentanone (2-)
1-Isobutyl-3-Methyl-2Pyrazoline
Dl-Alanyl-Dl-Leucine
Cyclohexane
.Alpha.,.Beta.-Gluco-Octonic
Acid Lactone
2,4-Pentanedione, 1,1,1,5,5,5HexafluoroN-Octadecane
2-Methylaminomethyl-1,3Dioxolane
D-(+)-Trehalose
Carbonic Acid, Allyl 3,5Difluophenyl Ester
M-Cresyl Acetate
3-Indoleacetic Acid
L-Ascorbic Acid
D-(+)-Galactose
S-[4-Cyanophenyl]-N,NDimethylthiocarbamate
Bis(Chloromethyl) Ether
2-Propenoic Acid, 3-Phenyl-,
Phenyl Ester, (E)Oleic Acid
2-Oxopentanoic Acid
L-Iditol
Bromobenzene
L-Valine
Eicosane

VIP
1.261

P-value
1.980E-04

1.260
1.248

2.370E-08
1.040E-02

1.241
1.221
1.220
1.210

8.050E-05
5.700E-04
1.180E-04
2.460E-02

1.195
1.180
1.148

2.640E-04
9.380E-05
4.640E-04

1.145

1.430E-02

1.142
1.132

1.660E-06
2.660E-05

1.130
1.125

1.180E-04
8.890E-03

1.107
1.098
1.097
1.092
1.091

3.010E-03
2.580E-02
1.470E-04
9.380E-05
1.270E-04

1.053
1.043

2.230E-02
1.840E-04

1.035
1.032
1.031
1.013
1.008
1.000

3.600E-03
5.080E-02
4.650E-09
4.080E-02
3.390E-03
2.080E-05
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VIP values obtained from the OPLS-DA model of non-volatile metabolites of flat vs.
fluffy and the P- values obtained from the Mann-Whitney U test
3.3.3

Biochemical pathways association to discriminant MP morphologies: flat from the
fluffy
The differential metabolites identified from the volatile and non-volatile OPLS-DA

models, were used for pathway enrichment analysis using MetaboAnalyst (default settings). Even
though 52 and 44 significant metabolites from analysis of non-volatile and volatile metabolites
were used as inputs to the pathway enrichment analysis in the MetaboAnalyst platform, a total of
33 metabolites were identified in the KEGG database as significant for the pathway analysis. The
pathway input data (KEGG IDs) and the resulting pathways are in Table B.4. As shown in Figure
3.10, valine, leucine, and isoleucine degradation, biosynthesis of unsaturated fatty acids, starch
and sucrose metabolism, galactose metabolism, pantothenate and CoA biosynthesis, amino sugar
and nucleotide sugar metabolism, glycolysis/ gluconeogenesis, and aminoacyl-tRNA biosynthesis
are the biochemical pathways that differentiate the two morphologies of the MP fungi.
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Figure 3.10

Metabolic pathways associated with the MP: flat and fluffy differentiation

The node color of the above pathway impact diagram is based on the p-value, and the size or
radius is based on the pathway impact values.
Alpha-D-glucose, alpha-alpha-trehalose, L-valine, octadecane, linoleic acid, and
methylmalonate are the metabolites associated with the above-described pathways that can be
used to differentiate the two morphological groups. Chun and Agathose reported that the L-valin
content of a fungus could be affected by the fungal mycelial growth and morphological
differentiation.117 Hence, the L-valine content of the fungal mycelium is positively correlated
with the fungal biomass. This phenomenon can be related to the fluffy morphology of the MP
fungi because they grow more densely and thicker than the flat strains.
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3.4

Conclusion
This study optimized a single-step metabolite extraction solvent mix to simultaneously

extract polar and non-polar metabolites from a filamentous fungal culture. Out of the tested six
different solvent mixtures, butanol: methanol: water (2:1:1, v/v) had the best polarity coverage of
the metabolites, relatively low mean CV% of all detected peaks, the highest number of metabolites
below 30% of the CV% and comparatively high protein precipitation efficiency.
This study also demonstrated the potential of broadening the metabolome coverage by
using two different analytical approaches to investigate the metabolome of a single species. The
volatile metabolome of the MP fungi was analyzed using an HS-SPLME coupled GC-MS, and the
non-volatile metabolome of the MP fungi was investigated with the TMS derivatization coupled
GC-MS. The combination of these two different GC-MS approaches helped to differentiate the
two distinct morphological types of MP fungi: flat and fluffy. A total of 44 volatile metabolites
and 52 non-volatiles metabolites were identified to distinguish the flat and fluffy morphologies of
the MP using the OPLS-DA predictive model building. The findings of this study may present a
novel single-step metabolite extraction solvent system to study lipidome and the metabolome using
the same cell lysate. Further studies of this solvent system can be done to look at the compatibility
with LC-MS metabolomics platforms. Also, this untargeted metabolomics approach of analyzing
the MP fungal metabolome may be used to launch a targeted metabolomics study of MP fungi to
investigate the pathogenicity associated with the two morphologies.
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CHAPTER IV
OPTIMIZED UNTARGETED METABOLOMICS APPROACH FOR THE ANALYSIS OF
MYCORRHIZAE FUNGI USING GC-MS
4.1

Introduction
Mycorrhizae are some of the most critical fungi on earth, forming symbiotic mutual

relationships with their host plant’s root system. This symbiosis is essential to plant nutrition
because plants get additional nutrients through the mycorrhizae network.118–120 Arbuscular
mycorrhizae (AM) fungi form a highly extended and branched hyphae network within the soil.
Interactions within the plant rhizosphere cause spores to mature and develop arbuscules within the
cortical cells of the host plant’s root. It is at this site that vital nutrient exchange occurs. The hyphae
take up mineral nutrients from the soil, transport them to the host plant's root system, and deposit
them into the arbuscular. In exchange, the roots supply the AM with lipids and fixed carbon in the
form of hexose sugars.121 122 By studying the interkingdom symbiosis of AM and soybean plants,
we can elucidate the metabolic pathways of this important fungus.
Within mycology, metabolomics is of key importance as it can provide diagnostic tools for
pathogenic fungal infestations. The assessment of the metabolome of differing fungi can elucidate
the biochemical processes inherent in the kingdom. Research into the metabolic processes of fungi
is presently lacking, especially so when considering AM. Metabolomics can shed light on the hostfungus relationship and how it promotes a plant’s tolerance of abiotic stressors related to escalating
climate change, increased temperature, salinity, heavy metal toxicity, radiation, and drought.
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At present, most research into metabolomics of the symbiotic relationship between a host
plant and an AM fungus has focused solely on the changes to the metabolome of the plant induced
by the AM fungus. This focus is not necessarily misguided as AM are obligate biotrophs. The
interface between an AM and its host roots cannot be separated, however, understanding the
individual roles of the AM and host metabolome, is essential. The distinction between the two will
allow future researchers to manipulate fungal metabolites to induce specific changes in the host
and potentially vice versa. Given that AM fungi are living organisms, they have a metabolome and
therefore metabolites. The dearth of research into their specific metabolisms presents difficulties
when assessing the role that AM plays in changing the inherent capabilities of the host plants to
the enhanced capabilities provided by the symbiotic association.
Mycorrhizae fungal metabolism has been previously studied, and almost all metabolites
were extracted from the AM colonized roots.123–127 A few studies were carried out using
mycorrhizae hyphal extracts, but in those cases, an in vitro monoxenic culture of mycorrhizae
fungi was used where scientists used a two-compartment Petry dish. In one compartment, the host
root (most often t-DNA transferred carrot roots) and the other compartment (hyphal compartment)
was where the fungi hyphae could be harvested.128,129 These studies focused on a specific pathway,
such as the central carbon mechanism or selective nutrient uptake. Therefore, there is a gap in the
study of the metabolome of the mycorrhizae fungi using fungal material. Here, we described an
untargeted metabolomics-based method to elucidate mycorrhizae fungi metabolome when under
salinity stress.
When considering the study of a particular species metabolome, it is crucial to start with
the development of a metabolite extraction method. There is no gold standard metabolite extraction
solvent mix or procedure that works for all biomaterial due to varied matrix effects. Therefore, this
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study first explored solvent mixtures (polar, non-polar, or mid-polar) to extract metabolites before
the salinity effect on mycorrhizal metabolism was studied.
4.2
4.2.1

Materials and Method
Chemicals, and reagents
Butanol (HPLC grade, Sigma-Aldrich), methanol, water, and acetonitrile, and isopropyl

alcohol in optima grade (Sigma-Aldrich) Pierce™ BCA Protein Assay Kit (Thermo Fisher
Scientific), O-methoxyamine hydrochloride, N-methyl-N-trimethylsilyl trifluoroacetamide
(MSTFA) (Sigma Aldrich), pyridine anhydrous (Sigma Aldrich), 2-chloro-phenyl alanine (Alfa
Aesar) were purchased and used as received.
4.2.2

Plant and fungal material
Commercially available pure fungal culture: Rhizophagus intraradices (Xtreme Gardening

#HGC721205, Mykos Pure Mycorrhizae Inoculant Organic Root Enhancer) was used in this
experiment. Soybean seeds (Johnny’s Selected Seeds- Viking 2265 Soybeans OG) were used to
grow host soybean plants. Mycorrhizae fungi were raised in a two-compartment pot with a host
plant (soybean) in a greenhouse environment. The architecture of the hyphal compartment (Figure
4.1) facilitated the extraction of the mycorrhizae fungal hyphae from the soil.
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Figure 4.1

A: Photograph showing the 2-compartment pot used to grow the AM.
B: Schematic diagram showing the arrangement of the 2 compartment HC: hyphal
compartment, and RC: root compartment

Sterilized soil for the root compartments comprised two parts sand and 1 part topsoil
mixture. The soybean seeds were surface sterilized using a 75% EtOH solution. Seeds were placed
into the EtOH solution and allowed to soak for 40 seconds, then rinsed three times using sterile
distilled water. The seeds were then soaked in sterile water for 24 h a day before planting. Pots
were also sterilized. After constructing the fungal compartments, it was sprayed with a 75% EtOH
solution and allowed to dry. Next, the 1-gallon pots were sprayed with a 20% bleach solution and
allowed to dry overnight. On planting day, the pots were once again sterilized, this time by
submerging them into a 20% bleach solution and allowing them to dry before filling with soil.
4.2.2.1

Fungal Compartment Design and Filling
The fungal compartments were designed according to the Neumann and George

protocol,130 so that the hyphae could pass through a mesh barrier, but the soybean roots could
not. Small plastic net pots, 50 mm in diameter, were used (xGarden Economy Net Pots). A 30-
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µm nylon mesh (Elko Filtering Co. Sefar Part #1: 03-30/20) was fixed to the outer surface of the
net pots with 100% silicone sealant to cover the pot’s openings.
After heat sterilization, according to the Neumann and George protocol,12 1 kg of sieved
soil (< 38 µm) was combined with 1 kg of glass beads (diameter: 2 mm glass beads,
Coleparmer.com) along with 200 mg K (K2SO4), 200 mg N (NH4NO3), 100 mg Mg (MgSO4), 50
mg P [Ca(H2PO4)2·H2O], 10 mg Zn (ZnSO4·H2O), 10 mg Na (Na2SO4) and 400 mL de-ionized
water. After thoroughly mixing, 110 g of the wet mixture was added to each sterile fungal
compartment. The pot filling mixture comprised the sieved soil and glass beads to allow better
recovery and quantification of extraradical mycelium.
To construct the complete pots, 1 cm of sterile sand was added to the bottom of the sterile
1-gallon pots, and 1 kg of the soil + sand mixture was mixed with 100 g of commercial mycorrhiza
inoculum (Xtreme Gardening #HGC721205, Mykos Pure Mycorrhizae Inoculant Organic Root
Enhancer). This mixture was added on top of the bottom sand layer. Six surface-sterilized seeds
were planted 1 cm deep around the border of the pot so as to make room for the fungal
compartments, which were inserted into the middle of the soil. Before insertion, the fungal
compartments were covered with adhesive tape on the top to prevent roots and soil from
permeating the compartment barrier. After placing the compartments into the pots and planting the
seeds, the soil was covered with an additional 1 cm layer of sterile sand. All pots were put into a
greenhouse in ambient conditions, along with adhesive fly traps arranged above the pots to
discourage insect interference. Non-mycorrhizae pots were prepared in the same way without
adding mycorrhizae inoculum.
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4.2.2.2

Culturing mycorrhizae fungi
Culturing of the mycorrhizae fungi was done allowing for a symbiotic relationship with

the soybean plants. There were two soybean plants per pot and one hyphal compartment
associated with that pot. Sterile water 100 mL was added to pots every three days. Ammonium
nitrate (0.01 M, 100 mlL was added to each pot once every two weeks.
4.2.2.3

Confirmation of the mycorrhizae root colonization
Soybean roots were cleaned thoroughly with running water and autoclaved for 60 min at

121 °C in a 10% KOH solution. Next, roots were again cleaned with running tap water before
being stained overnight using Typhan blue staining solution.13 Excess stain was removed from the
roots by dipping in 50% glycerol solution. The stained roots were observed under the light
microscope (LECA DM 1000) with 400 to 1000 magnification (Figure C.2).
4.2.2.4

Mycorrhizae hyphae and mycorrhizae colonized plant roots harvesting
Sixty d old plant pots and hyphal compartments were harvested. The hyphal compartment

was extracted using the wet sieving method with some modifications.12 Briefly, hyphal
compartment soil was dissolved in distilled water and filtered through a 38 µm mesh sieve to
separate glass beads and hyphae from the fine soil particles. Hyphae were collected with tweezers
with the help of high-intensity light and magnifying lenses (Figure C.1). 10 mg ± 0.2 mg hyphae
were weighed, put into Eppendorf tubes, frozen with liquid nitrogen, and stored at -80 °C until
analyzed. Plant roots were harvested and immediately rinsed with DI water, flash-frozen in liquid
nitrogen, and stored at -80 °C.
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4.2.2.5

A metabolite extraction method for the mycorrhizae fungi
Frozen hyphae containing Eppendorf tubes were removed from the -80 °C freezer, and 20

µL of 2-chlorophenylalanine (1 mg/1 mL) was added to the sample as an internal standard (IS).
Hyphae were disrupted in a bead beater for 30 s using 0.1 g of beads (diameter: 0.5 mm,
Zirconium-silicate). Frozen plant roots were pulverized using a mortar and pestle before 10 mg
was placed into the bead beater tube. After disrupting the plant cells, metabolites were solvent
extraction. Two extraction methods that were tested for mycorrhizae metabolites, including Ex 1)
butanol: methanol: water (2:2:1, v/v) at -20 °C, and Ex 2) isopropanol: acetonitrile: water (3:3:2,
v/v) at -20 °C.
After cell disruption, 0.5 mL of the solvent mix was added to the bead beater tube, and the
mixture was vortexed for 15 s and placed on ice for 15 s. This process was repeated four times.
The extraction tubes were stored at – 20 °C for 60 min to allow for protein precipitation. Next, the
extraction tubes were centrifuged at 14 000 × g for 15 min at 4 °C. Finally, 400 µL of the
supernatant was withdrawn and placed into a pre-cooled Eppendorf tube. The cell pellet was again
extracted with 0.5 mL of the solvent mix, and the procedure was repeated, and supernatants
combined after centrifugation.
4.2.2.6

Protein quantification
Proteins were calorimetrically quantified (at A 562 nm) using a BCA protein assay kit

(Pierce ™ BCA protein assay kit, ThermoScientific). 100 µL of the supernatant used in the BCA
analysis, as per manufacturer guidelines, to determine protein content in the solution phase using
UV-VIS spectrophotometry. Lyophilized cell pellets were ground using the mini bead beater with
0.1 g of beads (diameter: 0.5 mm, Zirconium-silicate) and 150 µL of protein extraction buffer (100
mM Tris HCl (pH 8), 1 mM EDTA, 150 mM NaCl, 1% Triton x) was added, vortexed vigorously,
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and incubated on ice for 15 min. Vortexing and incubation were repeated twice and centrifuged at
max speed for 5 mins. The cell lysate was used to quantify the precipitated protein.
4.2.2.6.1

Sample preparation for the GC-MS analysis

Initially, GC-MS was used to evaluate solvent mix selection. Next, 100 µL of the
metabolite extraction was dried and derivatized using a protocol described by Lisec et al.,124 with
some slight modifications. Briefly, dried metabolite crude was combined with 50 µL of Omethoxyamine hydrochloride (20 mg/1 mL in pyridine), vortexed for 30 s, and incubated at 37 °C
for 120 min. Then 50 µL of N-methyl-N-trimethylsilyl trifluoroacetamide (MSTFA) was added to
the Eppendorf tube, vortexed for the 30 s, and again incubated for 30 min at 37 °C. After the
incubation period, Eppendorf tubes were cooled to room temperature, and 20 µL of the retention
index mix was added, and vortexed for the 30 s. 85 µL of the derivatized mix was added to the
glass insert (200 µL), which was inserted into an amber color autosampler vial (2 mL) and sealed
using a cap equipped with a septum.
4.2.2.6.1.1

GC-MS analysis

GCMS analysis was performed using a Shimadzu (Tokyo, Japan) GC-MS (GC-2010 with
QP-2010) equipped with an auto-sampler (AOC-20i+s). The injection volume was set at 1 µL,
and the injector temperature was set at 250 °C in the splitless injection mode. Derivatized
metabolites were separated in an Rtx-5ms (Restek, Bellefonte, PA, USA) column (30 m × 0.25
mm× 0.25 µm, length × inner diameter × film thickness, respectively). UHP helium was used as
the carrier gas at the flow rate of 1 mL/min. GC temperature program started with the column
temperature set to 40 °C for 3 min, then ramped to 250 °C at the heating rate of 20 °C/min, and
held for 2 min, then again, the temperature was ramped to 280 °C at the heating rate of 25
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°C/min and held for 3 min. For MS detection, EI ionization was done at 70 eV, the ion source
temperature was set to 240 °C, and full scan acquisition was obtained over the 35-600 m/z range.
4.2.3

Salinity stress on mycorrhizae metabolome
Fifty-four days after mycorrhizae inoculation in the two-compartment system, plants were

watered with 100 mL of NaCl solution (0.01 M) a total of three times before the harvesting on the
60th day. The controls received 100 mL of de-ionized water in the same manner. Mycorrhizae
hyphae and roots were harvested as mentioned above. Metabolites were extracted using butanol:
methanol: water (2:1:1, v/v) solvent mix as described above. Extracted metabolites mixture was
evaporated, derivatized, and analyzed as mentioned in section 4.2.2.6.1
4.2.3.1

Quality control samples
Pooled extraction samples were prepared by combining 100 µL of each extraction to make

the pool QC sample. QC samples were injected after every 5 test samples and at the beginning and
the end of the GC-MS. 100 µL of the QC sample was derivatized as described above and used for
the GC-MS analysis. Solvent extraction blanks were analyzed the same way as described in section
4.2.2.6.1 without the hyphal material. Derivatization blanks were prepared with derivatization
reagents without the cell lysates.
4.2.3.2

Data analysis
Raw GC-MS data files were converted into NetCDF format using Shimatzu post-run

analysis software. These GC-MS spectra were subjected to default settings for deconvolution, peak
detection,

peak

matching,

and

retention

time

alignment

in

the

GNPS

platform

(https://gnps.ucsd.edu)81. Peak annotation was carried out using the GNPS library
search/Molecular networking GC workflow.14 Statistical analysis was done using the
97

MetaboAnalyst platform (https://www.metaboanalyst.ca).80 Data were normalized, logtransformed, and auto-scaled before the analysis. Principle component analysis (PCA) was used
to assure quality control of the metabolomics workflow. Partial least square discrimination analysis
(PLS-DA) was used to visualize group differentiation. Hierarchical Cluster Analysis (HCA) was
performed to generate heatmaps to show the features presented in the extracted mixtures. The
Mann-Whitney U-test was used to determine the significance (p-value < 0.05) of the features
detected in this analytical platform.
4.3

Results
A metabolite extraction method was developed to broaden the collection of the

mycorrhizae fungi metabolome. Two extraction methods that were used Ex 1) butanol: methanol:
water (2:2:1, v/v) at -20 °C, and Ex 2) isopropanol: acetonitrile: water (3:3:2, v/v) at -20 °C. The
butanol method was selected from a previous study (chapter 3 of this thesis), and the isopropanol
method was selected using a literature mycorrhizae-related plant metabolite extraction
method123,131 and is widely used as extraction solvent mixtures in metabolomics17,132–134 and
lipidomics135–138. There were 41 GC-MS spectra acquired, including QC, extraction, and
derivatization blanks. The reliability of the GC-MS platform was evaluated with PCA of the test
samples and the QC samples. As shown in Figure 4.2, all the QC samples are concentrated in the
PCA plot. Therefore, the variability of the GC-MS Platform was negligible during the analysis.
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Figure 4.2

A: PCA analysis of QC samples and test samples to show the quality control of the
study.
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Figure 4.2 (continued) PLS-DA analysis of all test samples and the QC samples
Sample groups displayed are, b1: Ex.1 extraction blanks, b2: Ex.2 extraction blanks, d blank:
derivatization reagent blanks, Ex.1 M: Ex.1 mycorrhizae hyphal extract, Ex.1 R: mycorrhizae
colonized root extract, Ex.2 M: mycorrhizae hyphal extract, Ex.2 R: mycorrhizae colonized root
extract, QC: pool QC samples of metabolite extractions.
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4.3.1

Optimization of the mycorrhizal fungal metabolites’ extraction solvent

Figure 4.3

Histograms of the distribution of CV% of hyphal and root extractions for Ex.1 and
Ex.2

The dotted line shows the 30% of the CV%

𝐶𝑜𝑒𝑓𝑓𝑖𝑒𝑛𝑡 𝑜𝑓 𝑣𝑎𝑟𝑖𝑎𝑡𝑖𝑜𝑛 (𝐶𝑉)% =

𝑆𝑡𝑎𝑛𝑑𝑎𝑟𝑑 𝑑𝑒𝑣𝑖𝑎𝑡𝑖𝑜𝑛
× 100
𝑚𝑒𝑎𝑛

(4.1)

The coefficient variation (CV) distribution of the signals produced from the two solvent
systems is displayed in the frequency distribution histogram in Figure 4.3. The typical CV% cutoff
for the GC-MS generated signals varies between 30-50%, higher than the LC-MS generated signal
CV% cutoff of 30%. This might be due to the several steps involved with the sample preparation
before injection into the analytical system.17 Figure 4.3 displays the signals below the cutoff mark
of 30% (dash line) among the tested 4 sample types. There were 137 GC-MS peaks detected for
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Ex 1 and Ex.2 hyphal and root extractions. Forty-seven peaks of Ex.1 hyphal extractions and 77
peaks of Ex.1 root extractions were below the 30% cutoff of the CV%. Sixty-five peaks of Ex.2
hyphal extractions, 59 peaks of Ex.2 root extractions were below the 30% cutoff of the CV%. The
mean CV% of the Ex.1 hyphal and root extractions was 38 and 53, respectively, and CV% of Ex.2
hyphal and root extractions was 53 and 26, respectively.

Figure 4.4

HCA of the average abundance of the metabolites presents in Ex.1 and Ex.2 of the
hyphal and root extractions
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Figure 4.5

The sum of all detected peak areas of TIC in Ex.1 and Ex.2 root and hyphal
extractions

Ex.1 is butanol: methanol: water (2:2:1, v/v) at -20 °C, and Ex.2 is isopropanol: acetonitrile:
water (3:3:2, v/v) at -20 °C.
HCA was performed using 11 metabolites (Figure 4.4). These metabolites were selected
because of their high peak areas (> 5000 counts) and presence in both types of extractions (hyphal
and tissue). Both extraction methods had the ability to extract metabolites of different polarities.
As shown in Figure 4.4, Ex.1 has slightly improved extraction of polar sugar molecules (Myoinositol), polar amino acids (arginine and asparagine), non-polar amino acids (proline and glycine),
and organic acids (succinic acid).
The sum of the TICs (Figure 4.5) can be used to estimate the total number of metabolites
extracted by the two different solvent systems roughly. Ex.1 had a greater number of extracted
metabolites in both hyphal and root extractions than Ex.2. This method provides only a rough
estimation of the extraction capacity of the solvent systems; however, solvent extractability should
be addressed to select a suitable extraction solvent mix.
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Figure 4.6

Hyphal protein precipitation efficiency

Protein precipitation is of great concern as proteins can obstruct the detection of small
molecules, including metabolites, in mass spectrometry-based platforms. Therefore, the protein
precipitation efficiency of both extraction solvent mixtures was measured. Protein content in the
extracted solvent supernatant and the protein content in the cell pellet was quantified using the
Bicinchoninic Acid (BCA) protein assay coupled with UV-VIS spectrophotometry. As shown in
Figure 4.6, both types of extraction solvent mixtures had competitive protein precipitation
efficiency. After evaluating metabolite extraction coverage (polar and non-polar) and the protein
precipitation efficiency, Ex.1: butanol: methanol: water (2:1:1, v/v) was selected for the further
analysis of mycorrhizae fungal metabolites.
4.3.2

Salinity stress effect on mycorrhizae fungal metabolism
The reliability of the analytical platforms was determined by plotting the QC samples with

the test samples in a PCA score plot. As shown in Figure 4.7, all QC samples are grouped together;
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therefore, the data generated from this platform can be used for further analysis. PLS-DA score
plot in figure 4.7 B shows the test group differentiation between stressed and non-stressed groups
and hyphal and root extracts. Reagents blanks also could use as pool QC samples to test if any
instrumental variations happen. Figure 4.7 B shows the PLS-DA score plot that demonstrates the
group separation of hyphae and roots. PLS-DA, a supervised method compared to the unsupervised
PCA, allows the group separation between hyphae and roots. As shown in Figure 4.8, the
differentially expressed chemicals in all sample groups might cause the separation of hyphae and
roots. For example, irrespective of the salinity stress, as illustrated in Figure 4.8, L-arginine, Lproline, trehalose, glycine, methionine, and mannitol content are high in hyphae compared to the
root material. We analyzed the salinity stressed and not stressed AM hyphal material as the AM
colonized root materials. But, this study is more focused on studying mycorrhizae metabolism.
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Figure 4.7

A: PCA score plot of all samples used in the salinity stress on the mycorrhizae
metabolism. B: PLS-DA score plot of all samples used in the salinity stress on the
mycorrhizae metabolism.
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Figure 4.7 (continued) A: PCA score plot of all samples used in the salinity stress on the
mycorrhizae metabolism. B: PLS-DA score plot of all samples used in the salinity stress on the
mycorrhizae metabolism.
Blank: derivatization blank, Ex. Blank: butanol/methanol/water extraction blank, HNS: hyphae
not stressed, HS: hyphae stressed, RNS: mycorrhizae colonized and not stress roots, RS:
mycorrhizae colonized and stressed roots, R: Mycorrhizae not colonized and not stressed root,
QC samples are concentrated into one point, and the blue arrow shows that area on the PCA plot
(A)
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Figure 4.8

Heat map showing the different chemicals/metabolites present in the various
sample groups. HNS: hyphae not stressed, HS: hyphae stressed, RNS: roots not
stressed, RS: root stressed.

Differentially expressed chemicals are marked on the heatmap. The group separations shown on
the PLS-DA score plot can be caused because of these variations among the different sample
groups.
4.3.2.1

The effect of salinity stress on the AM hyphae metabolome
Metabolites extracted from the salinity stress and non-stressed hyphal show a clear group

separation between these salinity-affected and non-affected groups. Materials were analyzed using
the PLS-DA model. The significant features contributing to this clear group separation were
filtered using VIP > 1 and p-value < 0.05. P-value was generated from the univariate analysis:
Mann-Whitney U test. The significant features which affected by the salinity stress are listed in
Table 4.1.
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Figure 4.9

PLS-DA score plot of hyphae stressed and non-stressed groups, B: Model
performance by ten-fold cross-validation R2 = 0.9, Q2 = 0.16, C: PLS-DA 1000
times permutation test

The Q2 of the PLS-DA models tells the model's accuracy, and R2 means the goodness of
the fit of the prediction model (Figure 4.9).139 This PLS-DA model constructed to differentiate
the salinity stressed, and non-stressed AM hyphae had good model fitting but less accuracy.
Therefore a 1000 times permutation test was carried out. The permutation results are listed in
Figure C.3. An additional parameter: P-value from the Mann-Whitney test, was used to find the
significant metabolites.
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Table 4.1

Differentiated metabolites in salinity stressed hyphae and non-stressed hyphae

Metabolite ID
Benzoic acid
D-(+)-Trehalose
D-(+)-Glucose
2,6-Dimethylcyclohexanone
Nicotinuric acid
Succinic acid
L-Leucine
Cyclohexanone
Dimethyl palmitamine
Gluconolactone
pentanone (2-)
Allantoin
Acetylcholine
Butylmethylsilane
D-Xylulose
L-Arginine
Cinnamaldehyde
Methylethylmalonic acid
Methionine
4-Fluorothiophenol
Uracil
Cyclopropanecarboxamide, N(2-pentyl)-N-methylTrifluoromethanesulfonic
anhydride
Myo-Inositol
Creatine
Glycerol
Mannitol
L-Ascorbic acid
L-Malic acid
D-Fructose
L-Tyrosine
L-Proline
4-Methylcyclohexylamine
L-Valine

p- value *
8.00E-04
5.83E-04
5.83E-04
5.83E-04
5.83E-04
5.83E-04
5.83E-04
5.83E-04
5.83E-04
5.83E-04
4.08E-03
5.83E-04
2.33E-03
5.83E-04
5.83E-04
5.83E-04
5.83E-04
2.62E-02
1.17E-03
4.08E-03
4.08E-03
5.83E-04

VIP#
1.427
1.386
1.331
1.276
1.272
1.262
1.257
1.257
1.249
1.230
1.225
1.210
1.172
1.171
1.171
1.128
1.124
1.114
1.088
1.085
1.061

2.62E-02

1.058

5.83E-04
1.75E-02
1.11E-02
5.83E-04
3.13E-03
2.50E-05
2.62E-02
1.40E-05
6.00E-04
4.60E-05
2.60E-05

1.050
1.023
0.993
0.950
0.887
0.840
0.783
0.750
0.669
0.663
0.590

* p- value calculated from Mann Whitney U test
# VIP calculated from the PLS-DA
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Table 4.1 (continued)
Metabolite ID
Hexamethyldisilazane
oxalic acid
D-Mannose
Dihydrouracil
Glycine

p- value *
3.15E-03
1.25E-03
8.75E-03
2.54E-03
1.25E-04

VIP#
0.383
0.331
0.256
0.115
0.107

* p- value calculated from Mann Whitney U test
# VIP calculated from the PLS-DA model building

The differential metabolites were obtained by considering both PLS-DA generated VIP
values (1 < VIP) and p-value < 0.05. Metabolites should pass both criteria to be significant
metabolites (bold in Table 4.1).
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Figure 4.10

Metabolomic pathway analysis, A: an overview of the pathway analysis, 1:
Glycerolipid metabolism, 2: glycine, serine metabolism, 3: cystine, methionine
metabolism, 4: glyoxylate metabolism, 5: B: glycerolipid metabolism pathway

A: The node color of the 4.10 A, node color based on the p-value, and the radius of the node is
based on the impact value of the pathways.
B: Pathway map created from the KEGG reference map on the MetaboAnalyst platform. The
light blue boxes in the pathway map were absent in the data set but are used in the background
for the pathway enrichment analysis, and the red box indicates the presence of the metabolite in
the subject data set, CO numbers are the KEGG ids, in this case, C00116=glycerol
In this study, we found the glycerolipid metabolism pathway (Figure 4.10) as the highest
impacted pathway upon the salinity stress on mycorrhizal hyphae.
When working on analyzing metabolites, it is crucial to perform a quick procedure to
reduce the variation in metabolites. In short, the extracted metabolites should display a snapshot
of the metabolome of that species. In the case of mycorrhizae metabolome studies, mycorrhizae
hyphae should be extracted from the soil first. This step should be done very quickly to reduce any
changes. In this study, we used Neumann and George protocol130 and modified it to provide fast
harvesting (~2 min) of the mycorrhizae hyphae. The presence of the glomalin protein and the
112

clumping or aggregating nature of that glycoprotein in the water systems facilitated the quick
harvesting procedure applied in this study. Glomalin is a glycoprotein produced in the AM hyphal
cell wall.140 The extracted hyphae and the mycorrhizal root colonization confirmation are
demonstrated in Figure C.1 and Figure C.3, respectively.
The main goal of this study is to develop a protocol to extract the mycorrhizae metabolome
and apply that extraction protocol to study metabolite perturbations with abiotic stress. Salinity
stress on the mycorrhizae metabolome was chosen because salinity is a significant concern in
agriculture.141,142 Metabolites extraction from the fungal hyphae was a study priority, but a parallel
study was done on mycorrhizae colonized root metabolites extraction because of the obligate
nature of the mycorrhizae with the goal to determine if its metabolome was highly dependent on
the root metabolome.
The symbiotic relationship of the AM and the plant enabled tolerance against many abiotic
stresses.143 Plant stressors are increasing with global warming. Therefore, it is vital to understand
metabolome perturbations in mycorrhizal fungi when under stress. Most of the mycorrhizae
symbiotic metabolomics were done with AM colonized root extractions. This might be because
there was inadequate fungal material available to perform a metabolite extraction and/or the
practical difficulties associated with hyphal extraction from a complex soil mixture. This
experiment extracted a maximum of ~20 mg of hyphal material (wet biomass) from 100 g of
hyphal compartment soil mixture (soil: glass beads, 1:1).
Salinity is one of the most important abiotic stresses in agriculture. Therefore, it is crucial
to analyze the metabolome perturbation and pathways associated with salinity stress on the
mycorrhizae-plant symbiotic relationship. Salt stress affects whole plant mechanisms, such as
photosynthesis, nutrient uptake, microbial-plant interactions, and other metabolomics
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pathways.144,145 Salinity negatively affects both parties of the mycorrhizae-plant symbiotic
relationship. But in this study, we did not see much difference in the fungal hyphal biomass in saltstressed AM and non-salt-stressed AM. This might be due to the short-term (7 d) stress application
on the AM.
The AM carbohydrate metabolism has been extensively studied. It can be different in the
symbiosis or spore-like state of the AM fungi. Carbon uptake of the intra radical hyphae can
deviate from carbon uptake in the extra radical hyphae.122,146,147 Typically, intra radical hyphae
gets it carbon source as hexose from the host plant, which is then converted through intraradical
hyphae and transferred to the extra radical hyphae.147 We found more highly expressed glycerol
content in the stressed hyphae compared to the non-stressed hyphae. Glycerol metabolism had the
highest impact due to stress of any pathway with this study. Clearly glycerol metabolism is directly
impacted by stress conditions. Glycerol-like lipids synthesis when under stress conditions happens
for many reasons. When under biotic or abiotic stress, hyphae often transition to an asymbiotic or
inactive phase where AM produces glycerol or lipid-like storage molecules to survive the stressed
condition. The glyoxylate pathway is another highly expressed pathway in mycorrhiza
metabolism. AM can convert acetate into acetyl CoA in glyoxylate pathways and bypass
decarboxylation in the citric acid pathway.122 The presence of oxalic acid could also be due to the
glyoxylate pathway.148 In a study conducted by Lammers et al., the glyoxylate cycle was
illuminated as a critical feature in AM metabolism of carbon.122
Trehalose is a sugar molecule with two glucose units, highly expressed in the AM
symbiotic phase.17,20 While there was low or no mannitol in the symbiosis phase, however, in
contrast to a published study 131, we found mannitol in stressed hyphal tissues. Mannitol can protect
against reactive oxygen species (ROS) and is an osmolyte.149 Therefore, it helps cells to survive in
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salt stress conditions. During salt stress, we found high fructose levels compared to the other
sugars. Fructose, mannose, and galactose were high in stressed hyphal extract, glucose high in
stressed root extract, and Myo-inositol high in the non-stressed root.
Arginine is highly presented in the mycorrhizae fungal hyphae in ambient conditions. The
heat maps also showed high arginine expression in the fungal hyphae when under salinity stress.
Fellbum et al. reported that roots use mycorrhizae for nitrogen translocation via catabolic reaction
of the urea cycle.128 Therefore, arginine might be used to produce urea and then ammonium ions.
In this study, we observed urea and creatine expression in both mycorrhizae hyphae and the AM
colonized roots. Methionine expression was also high in stressed hyphae. Campbell et al.; reported
that methionine could act as ROS scavengers because the S in the methionine can be oxidized into
a sulfoxide.150,151 There is high proline and glycine content in the root metabolome during salinity
stress which might help to mitigate stress. Glycine levels are high in stressed roots, while proline
is highly expressed in hyphal extracts with and without the salinity stress. It is reported that the
proline could be high in AM as a shielding mechanism for plant defense.144 Proline is an
osmoprotectant chemical.144,152 Evidence from this study supports this because there is a high
expression of proline in salinity-stressed roots compared to the non-stressed roots. In both
circumstances (stressed and non-stressed), proline is expressed in the mycorrhizae metabolome.
Glycine expressed remarkably during salt stress on both hyphal and root metabolism and could
also act as an osmoprotectant.153
When stressed or not, free amino acids such as tyrosine, valine, glycine, proline,
methionine, and arginine are highly abundant in fungal hyphae compared to the root extracts.
These amino acids decreased in abundance with the salt stress applied to the AM. The abundant
free amino acids represent the highly energetic nature of the species,154 and mycorrhiza symbiosis
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with the host root system is considered to be a highly energetic or metabolically active state. This
could promote access to additional soil nutrients, thereby broadening the nutrient accessibility of
the host roots. However, free amino acids decreased with salinity stress, perhaps because fungal
cells were preparing for hibernation. Organic acids such as succinic, benzoic, and malic acids were
down-regulated with salinity stress, while oxalic acid was up-regulated in mycorrhizae. This might
be due to the activation of the glyoxylate pathway in the hyphae.144
Organic acids, such as succinic acid, benzoic acid, malic acid, malonic acid, and oxalic
acid, are highly expressed in salt-stressed roots. Li et al.; suggested that this high organic acid
content would facilitate root system mineral acquisition, especially ortho-phosphate absorbance.148
4.4

Conclusion
Of the two solvent systems, the butanol: methanol: water (2:1:1, v/v) system provided the

higher extraction capability of the mycorrhizae fungal and the mycorrhizae colonized root
metabolites. This solvent system also had broad metabolome coverage from more polar amino
acid-like arginine-like chemicals to non-polar amino acids such as proline and glycine. Arginine
and proline are natively high in mycorrhizae fungi, and the expression of these amino acids
increases with salinity stress. Because these amino acids act as osmoprotectant chemicals, they
may serve to mitigate stress. The mycorrhizae colonized root metabolome (mycorrhizae intra
radical metabolome), and the mycorrhizae fungal hyphae metabolome are not entirely overlapping.
The presence of high glycerol content in the mycorrhizae hyphae during salinity stress and low
glycerol abundance in the root metabolome supports this conclusion. The glycerol lipid
metabolism pathway is highly active in mycorrhizae fungi when stressed. Glycine, serine
metabolism, cysteine, methionine metabolism, and the glyoxylate pathways are also impacted
when stressed from high salinity.
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APPENDIX A
SUPPLEMENTARY MATERIAL FOR VOLATILE BIOMARKERS FOR THE EARLYSTAGE DISEASE DIAGNOSIS OF SWEET POTATOES
FUNGAL SOFT TISSUE DISEASE
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A.1

Disease progression observation
Abbreviations
SP: Sweet potato
ST: Soft tissues
WH: White hyphae

Table A.1
Days after
infection
1

2

3

4

Disease progression observation
SP #1

SP #2

SP #3

SP #4

SP #5

WH on
inoculated site
1/3
No Wrinkles

No WH

No WH

No WH

No Wrinkles

No ST
1
WH on
inoculated site
1/3
No Wrinkles

No ST
0
No WH

No
Wrinkles
No ST
0
No WH

No
Wrinkles
No ST
0
No WH

20% ST
2
WH on
inoculated site
2/3
No Wrinkles

5% ST
1
No WH

No
Wrinkles
15% ST
1
No WH

No
Wrinkles
25% ST
1
No WH

30% ST
2
WH on
inoculated site
2/3
No Wrinkles

10% ST
1
No WH

No
Wrinkles
20% ST
2
No WH

No
Wrinkles
30% ST
2
No WH

30% ST
2

15% ST
2

No
Wrinkles
25% ST
2

No
Wrinkles
35% ST
2

WH on
inoculated
site 2/3
No
Wrinkles
No ST
1
WH on
inoculated
site 2/3
Very little
Wrinkles
30% ST
2
WH on
inoculated
site 2/3
Very little
Wrinkles
30% ST
2
WH on
inoculated
site 2/3
Very little
Wrinkles
45% ST
2

No Wrinkles

No Wrinkles

No Wrinkles
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Table A.1 (continued)
Days after
infection
5

7

SP #1

SP #2

SP #3

SP #4

WH on
inoculated site
2/3

WH very little
on skin

WH very
little on
skin

wrinkles

No Wrinkles

40% ST
3
WH on
inoculated site
2/3, more than
day 5

15% ST
2
WH very little
on skin

Very little
wrinkles
25% ST
2
WH on
inoculated
site 1/3

WH on
WH very
inoculated little but
site 2/3
more than
day 4
No
Wrinkles
Wrinkles
40% ST
45% ST
3
3
WH on
WH
inoculated covered
site 1/3
40%
but
growing
fast
Very little Wrinkles
wrinkles
45% ST
50% ST
3
3
WH
WH
covered
covered
20%
90%
Wrinkles Wrinkles

Wrinkles

10

14

Wrinkles

Wrinkles

40% ST
3
WH covered
20%

20% ST
3
WH very little
on skin

Very little
wrinkles
45% ST
3
WH covered
30%

Wrinkles

40% ST
3
WH on
inoculated
site 1/3
Wrinkles

Wrinkles

Wrinkles

50% ST
3

60% ST
4

30% ST
3
WH covered
50%
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45% ST
3
WH
covered
20%
More
Wrinkles
50% ST
3

SP #5

50% ST
3
WH
covered
60%
Wrinkles

50 % ST
4*
WH
covered
90%
Wrinkles

75% ST
5

50% ST
4

Table A.1 (continued)
Days after
infection
21

28

SP #1

SP #2

SP #3

SP #4

SP #5

WH covered
50%

WH covered
80%

WH
covered
40%

WH
covered
50%

Wrinkles

Wrinkles

Wrinkles

80% ST
4

75% ST
4

More
Wrinkles
60% ST
3

WH
covered
100%,
black
spores
Wrinkles

90% ST
5

99% ST
5

WH covered
60%

WH covered
95%

WH
covered
60%

WH
covered
60%

Wrinkles

More Wrinkles

More
Wrinkles
95% ST
5

Wrinkles

WH
covered
100%,
black
spores
Wrinkles

100% ST
5

99% ST
5

90% ST
100% ST
5
5
Disease progression monitoring scale

Key 0: No hyphae/no soft tissues (ST)/no wrinkles
Key 1: Hyphae on inoculated site, ST >10%
Key 2: Hyphae on inoculated site, skin/ST >25%
Key 3: Hyphae intensely growing, 25%< ST >50%, wrinkles
Key 4: Hyphae covers > 50%, soft tissues > 50%
Key 5: Hyphae covers 100%/ST >75%
Stage 1 or eary stage of disease progression = key 0, 1, 2, and 3
Stage 2 or later stage = key 4,5
Stage 1 was considered as early stage of the disease and stage 2 and was considered as later stage
of the fungal soft tissue disease in sweet potatoes.
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A.2

Evaluation of the reliability of the analytical platform

Table A.2

HS SPME GC-MS workflow evaluation with QC samples

Name

Ethyl acetate
RT(min)

2-Butanone,3hydroxy, RT(min)

Cyclopentane, methyl
RT(min)

QCL 3

7.689

10.594

17.66

QCL 13

7.707

10.578

17.663

QCL 23

7.704

10.568

17.665

QCL 5

7.696

10.56

17.66

QCL 25

7.704

10.556

17.657

mean

7.700

10.5712

17.661

SD

0.00738

0.01527

0.00308

%RSD
0.09588
0.14446
0.01745
The analytical platform (HS-SPME GC-MS) had good retention time repeatability (SD ≤0.02).
Retention time shift was evaluated instead of the variation of the peak area throughout this study,
because of this study focused on qualitative analysis (presence of biomarkers) and not with the
quantitative analysis
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A.3

Control vs. Disease

Table A.3

Performance assessment of the potential biomarkers obtained from OPLS-DA
model 1 (control vs. disease)

Compound ID
RT (min)
AUC**
P-value**
Ethyl alcohol*
4.81
0.958
9.68E-25
1-Propanol*
6.29
0.985
2.66E-29
Ethyl Acetate*
7.69
0.914
5.93E-17
Butane, 2,3-dimethyl8.03
0.962
1.02E-15
Ethyl propionate*
11.17
0.924
2.26E-16
3-Buten-ol,3-methyl-*
12.07
0.899
3.39E-12
Allyl isovalerate
12.49
0.973
2.31E-20
Prenol*
14.29
0.830
2.14E-07
1,3-Pentadiene, 2,4-dimethyl15.21
0.947
5.46E-17
Cyclopentane, methyl17.6
0.867
9.49E-14
Compound ID
RT (min)
AUC**
P-value**
Ethyl crotonate*
17.77
0.850
9.6E-10
Ethyl isovalerate*
18.54
0.846
1.03E-09
Anisole*
21.88
0.908
2.46E-07
Butanoic acid, 3-hydroxy-,
ethyl ester
22.31
0.928
6.02E-17
*Level 1 identified compounds
**AUC and p-values were generated from the univariate ROC analysis using MetaboAnalyst.
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Figure A.1

PCA score plot of disease sweet potatoes (stage 1, 2, and 3) vs control sweet
potatoes. R2X(cum) = 0.447, Q2(cum) = 0.253, N = 96

A PCA plot results in a clear separation of the control group (green circles) from the disease
group (blue circles). The sweet potatoes of day one after the inoculation trend towards the
control group, but they were not considered to be outliers since the disease progression is still
very early. Day 28, after inoculating data (D 28 I1 and D 28 I4), also looks like outliers since
they are out of the 95% CI margin of the PCA plot. They were also retained for further analysis
since they were not outliers for the OPLS-DA.
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Figure A.2

The time course (from day 1 to day 28) emission of discriminating features
obtained from the OPLS-DA model (control vs disease). The y- axis is the sumnormalized peak areas of differentiating features. Control potatoes emission is
indicated by the letter c.
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Figure A.3

Summary of the multivariate analysis of disease sweet potatoes and control sweet
Potatoes a: OPLS-DA score plot, b: Loading plot, c: permutation (999) test
Numbers of components: 1+2+0, N=96 R2X(cum) = 0.302, R2Y(cum) = 0.974
Q2(cum) = 0.932
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Figure A.3 (continued) Summary of the multivariate analysis of disease sweet potatoes and
control sweet Potatoes a: OPLS-DA score plot, b: Loading plot, c: permutation (999) test
Numbers of components: 1+2+0, N=96 R2X(cum) = 0.302, R2Y(cum) = 0.974 Q2(cum) = 0.932
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A.4

Control vs. Stage 1

Figure A.4

PCA score plot of control (green circles) vs. stage 1 diseased (blue circles)
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Figure A.5

Summary of multivariate analysis of stage 1 disease sweet potatoes and control
sweet potatoes a: OPLS-DA score plot, b: Loading plot, c: permutation (999) test
Numbers of components: 1+1+0, N = 68 R2X(cum) = 0.443, R2Y(cum) = 0.979
Q2(cum) = 0.932
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Figure A.5 (continued) Summary of multivariate analysis of stage 1 disease sweet
potatoes and control sweet potatoes a: OPLS-DA score plot, b: Loading plot, c: permutation
(999) test
Numbers of components: 1+1+0, N = 68 R2X(cum) = 0.443, R2Y(cum) = 0.979 Q2(cum) =
0.932
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Table A.4

Performance assessment of the potential biomarkers obtained from OPLS-DA
model 1 (control vs. stage 1)

Compound ID
Rt (min)
AUC
P-value
3-Buten-ol,3-methyl-*
12.07
0.9189
4.12E-08
Ethyl propionate*
11.17
0.9341
8.02E-11
3-Hydroxypyridine monoacetate
28.88
0.9240
3.62E-14
Sorbic acid vinyl ester
22.99
0.9807
2.45E-14
Fenchone
28.09
0.9990
2.26E-22
l-Menthone*
26.86
0.9585
5.24E-15
Benzaldehyde, 4-(1-methylethyl)30.08
0.9595
6.07E-13
Prenol*
14.29
0.8632
2.09E-06
3,3-Dimethoxypropiophenone
21.88
0.9514
1.16E-07
Ethyl alcohol*
4.81
0.9362
1.07E-13
Bis(2-furfuryl)disulfide
11.61
0.9179
8.19E-06
1-Propanol*
6.29
0.9666
8.47E-16
Cyclopentane, methyl17.6
0.8207
1.8E-06
Benzaldehyde, 2,5-dimethyl28.19
0.8835
2.42E-07
Meta-ethylphenol
33.52
0.8146
5.48E-08
Compound ID
Rt (min)
AUC
P-value
Allyl 2,4-hexadienoate
29.03
0.9443
3.51E-10
trans,trans-3,5-Heptadien-2-one
14.92
0.7994
7E-09
*Level 1 identified compounds
AUC and p values were generated from the univariate ROC analysis
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A.5

R. stolonifer cultures vs basal media

Figure A.6

PCA score plot of R. stolonifer VOCs (blue circles) vs basal media VOCs (green
circles) (N = 27)
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Figure A.7

a: OPLS-DA score plot showing the discrimination of R. stolonifer VOCs from the
basal media.
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Figure A.7 (continued) b: S-plot of the OPLS-DA R. stolonifer VOCs model, and c: loading plot
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Figure A.7 (continued) d: the model performance evaluation obtained from the OPLS-DA
analysis.
Each blue triangle in Figure A.7 a, represents a sample and green circle used for the control basal
media samples. (R2X (cum) = 0.468, R2Y (cum) = 0.986, Q2 (cum) = 0.967, N = 66)
Table A.5

Features identified from the OPLS-DA (R. stolonifer cultures vs basal media)

Compound ID
3-Methyl-1-butanol*
3-Buten-1-ol, 3-methyl-*
2 Butanol*
Pentane, 2,2,4,4-tetramethylEthyl lactate
Ethyl alcohol*
1,4-Dimethoxybutane
Phenyl propyl ether
Dimethyl disulfide
3-hydroxy-2-butanone
Phenyl acetate

Rt
(min)
12.36
12.23
7.22
12.58
14.13
4.73
15.69
12.99
13.04
10.62
24.08

p(corr)
0.922116
0.796175
0.793897
0.741599
0.63128
0.624076
0.600919
0.548844
0.504972
0.503319
0.497667
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VIP
1.96843
1.97517
1.58914
2.04646
1.1491
1.16636
1.22283
1.26193
1.02208
1.56191
1.33369

APPENDIX B
EVALUATION OF EXTRACTION METHODOLOGIES FOR FUNGI: MACROPHOMINA
PHASEOLINA AND CHARACTERISTIC VOLATILE AND NON-VOLATILE
METABOLITES FOR DISCRIMINATING FLAT
AND FLUFFY MORPHOLOGIES
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B.1

Compounds detected from the solvent extraction optimizing experiment

Table B.1
RT (min)
3.06
3.06
3.06
3.06
3.13
3.13
3.13
3.27
3.27
3.39
3.39
3.39
3.47
3.47
3.54
3.58
3.67
3.67
3.86
3.86
3.90
3.95
4.00
4.00
4.00
4.05
4.05
4.05
4.05
4.05
4.16
4.16

Compounds identified from the solvent extraction optimization
Library ID
Diethanolamine
(2S,3R)-Butan-1,2,3,4-Tetraol 2,4-Isopropylidene
Acetal
Disilane, HexamethylDicyclopentadiene
Disiloxane, HexamethylCreatine
Tetracosylamine, N,N-DimethylN-Methylflindersine
3,4,5-Trimethoxybenzoic Acid Methyl Ester
Benzene
Pyridazine
2-Propenenitrile
Acetic Acid, Chloro4-Pyridinecarboxylic Acid Methyl Ester
1-Propyne, 3-Chloro2-Pyridinecarboxylic Acid
Chloromethane
Bis(Chloromethyl) Ether
Sulfurous Acid, Dimethyl Ester
2-Propenenitrile, 2-Chloro1,5-Hexadiyne
(.Eta.<6>-Methoxybenzene) Chromium Tricarbonyl
Nicotinuric Acid
2-Propanol, 1,3-DichloroFumaronitrile
Methyl Hexanoate
Propane, 1,1,3,3-Tetramethoxy1-Methoxy-2-Propanol
Propanenitrile, 2,2-DimethylBicyclo[2.2.2]Oct-2-Ene
Ethanol, Tms Derivative
Methanol, Tms Derivative
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MQScore
0.80
0.82
0.90
0.90
0.96
0.87
0.81
0.95
0.91
0.89
0.85
0.82
0.91
0.84
0.99
0.82
0.82
0.82
0.89
0.85
0.86
0.83
0.81
0.88
0.99
0.83
0.98
0.95
0.89
0.81
0.99
0.88

Table B.1 (continued)
RT (min)
4.16
4.16
4.19
4.19
4.19
4.19
4.26
4.26
4.26
4.26
4.26
4.31
4.40
4.40
4.40
4.40
4.57
4.57
4.61
4.61
4.61
4.65
4.73
4.73
4.76
4.76
4.76
4.81
4.81
4.86
4.89
4.89
4.93

Library ID
Benzofuran, 2-Methyl1-Hexyn-3-Ol, 3,5-DimethylTert-Butyldimethylsiloxybutane
Methanol, (Trimethylsilyl)-, Acetate
1,3-Diaminopropane
3,6-Dimethyl-1-Heptyn-3-Ol
1-Phenyl-2-Trimethylsilylcyclopropane
2-(2,3-Ditrimethylsilyloxybutoxy)-N-(2(Dimethylamino)Ethyl)-4-Quinolinecarboxamide
2-Phenylpropanal Ethylene Glycol Acetal
Citraconic Acid
(4S,5S)-(+)-5-Amino-2,2-Dimethyl-4-Phenyl-1,3Dioxane
Isoamyl Lactate
N-Methyltrifluoroacetamide, Tms Derivative
Methane, IsothiocyanatoCyclo-(D-Leu-L-Trp)
Boron, Trihydro(Pyridine)-, (T-4)7-Cyano-2-Ethyl-5,8-Dimethoxy-1,3,4,9Tetraazaphenalene
Urea, N,N'-Dimethyl-N,N'-Diphenyl2-Ethylhexanal Ethylene Glycol Acetal
Benzenamine, 4,4'-OxybisTert-Butyl(3-Methyl-2-Butenyl)Amine
Naphthalene
Acetamide, 2,2,2-Trifluoro-N-Methyl6-Phosphogluconic Acid
2-[2-[2-Methoxyethoxy]Ethoxy-1,3-Dioxalane
2-(3-Trimethylsilyloxybutoxy)-N-(2(Diethylamino)Ethyl)-4-Quinolinecarboxamide
1H-Indole-3-Acetic Acid, 5-Hydroxy1,2-Diethyl-1,2-Dimethyldisilane
1,1,1,2-Tetramethyldisilane
O-(P-Nitrophenyl) (2-(PNitrophenoxycarbonylthio)Ethyl)Thiocarbamate
Disiloxane, 1,3-Diethenyl-1,1,3,3-TetramethylCyclo-(D-Ile-L-Trp)
5-(2-Aminopropyl)-2-Methylphenol
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MQScore
0.88
0.85
0.90
0.80
0.90
0.88
0.84
0.83
0.99
0.98
0.83
0.91
0.88
0.84
0.82
0.86
0.83
0.82
0.87
0.94
0.83
0.99
0.85
0.95
0.80
1.00
0.85
0.81
0.90
0.91
0.94
0.82
0.84

Table B.1 (continued)
RT (min)
4.93
4.98
4.98
4.98
5.02
5.02
5.09
5.09
5.14
5.14
5.14
5.24
5.24
5.31
5.31
5.33
5.41
5.51
5.51
5.51
5.51
5.51
5.59
5.59
5.59
5.73
5.73
5.73
5.73
5.84
5.84
5.92
5.92
5.92
5.96

Library ID
Cotinine
L-Alanine Ethylamide, (S)Tetramethylsilane
Aniline Chromium Tricarbonyl
Diethylene Glycol Dimethyl Ether
Hexamethyldisilazane
1,2-Dimethyl-1,2-Dipropyldisilane
Norleucine
(Z)-5-Methoxy-3,5-Dimethyl-2Hexenyltrimethylsilane
Trimethylsilylmethanol
Acetic Acid 3-Methoxy-3-Methylbutyl Ester
Imidodicarbonic Diamide
2,5-Dimethyl-2-Phenyl-1,1-Dimethoxy-4-Hexene
Triethylene Glycol Monomethyl Ether
1,1-Dimethylsilacyclobutane
Undecanol (N-)
Ethanimidic Acid, N-(Trimethylsilyl)-, Trimethylsilyl
Ester
S-Methylcysteine
Tris(Trimethylsiloxy)Ethylene
Glycolic Acid
Hydroxylamine
Hexamethyldisiloxane
Dihydrouracil
D-Glucitol, 1,4-AnhydroMalonic Acid
5-Nonanone
Citrulline
Isoleucine
D-Fructose 6-Phosphate
2,5-Diethoxy-3-Methyl-3-Vinylhexane
Hexanamide, N-Propyl-N-IsobutylDl-Norvaline
D-Glucose-6-Phosphate
Piperidine, 2,2,6,6-TetramethylD-Ribose 5-Phosphate
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MQScore
0.82
0.87
0.84
0.81
0.93
0.91
0.89
0.88
0.90
0.83
0.81
0.96
0.94
0.97
0.81
0.94
0.87
0.86
0.85
0.83
0.82
0.99
0.85
0.89
0.99
0.92
0.96
0.95
0.94
0.84
0.82
0.84
0.95
0.89
0.98

Table B.1 (continued)
RT (min)
5.96
5.96
5.99
5.99
5.99
5.99
5.99
6.05
6.05
6.14
6.14
6.14
6.24
6.24
6.24
6.36
6.36
6.39
6.39
6.39
6.45
6.56
6.56
6.56
6.56
6.63
6.63
6.63
6.71
6.71
6.71
6.85
6.85
6.96
7.06
7.06

Library ID
4-Methylcyclohexylamine
Phosphoenolpyruvic Acid
Methylmalonic Acid-Di-Tms
Glycerol
Phosphoric Acid
18-Methylnonadecanoic Acid Trimethylsilylester
Hexadecyltrimethylammonium Bromide
Succinic Acid
Dl-Alanyl-L-Alanine
3-Methylglutaric Acid Di-Tms
Pentamethyldisilane
Oxalic Acid
Octadecane
D-Glycero-L-Manno-Heptonic Acid, .Gamma.Lactone
Octen-1-Al (2E)
,2-Dimethylbutane
5-Methyl-1,3-Cyclohexanedione
L-Serine
Ethylmalonic Acid
Pentanone (2-)
Cefaclor
L-Threonine
L-Alanine
Lactic Acid-Di-Tms
Sarcosine
L-Arginine
Tris(2-Methoxyethyl)Borate
N-(3-Trimethylsilyloxypropyl)Morpholine
3-Hexenyltrimethylsilane
Ibuprofen
Ethotoin
Cyclohexane
Isoamyl Laurate
D-(+)-Malic Acid
Tridecane
1,3-Dihydroxyacetone Dimer
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MQScore
0.99
0.89
0.91
0.90
0.90
0.95
0.98
0.82
0.82
0.85
0.84
0.95
0.87
0.90
0.90
0.83
0.90
0.85
0.82
0.81
0.80
0.83
0.81
0.81
0.99
0.90
0.83
0.83
0.82
0.98
0.86
0.81
0.93
0.86
0.95
0.95

Table B.1 (continued)
RT (min)
7.06
7.12
7.12
7.12
7.12
7.20
7.20
7.26
7.31
7.31
7.37
7.37
7.41
7.41
7.45
7.48
7.54
7.54
7.54
7.54
7.64
7.64
7.64
7.72
7.72
7.72
7.80
7.80
7.88
7.88
7.98
7.98
8.06
8.14
8.22
8.25
8.25

Library ID
L-Proline, N-(5-Bromovaleryl)-, Propyl Ester
Hexadecane
N-Octadecane
Bis(Trimethylsilyl)Trifluoroacetamide
Hexanamide, N-(2-Butyl)-N-MethylL-Aspartic Acid
Alpha-Methyl-Dl-Serine
Pyrrolidonecarboxylic Acid
L-Pyroglutamic Acid-Di-Tms
L-Glutamine
Dl-Alanyl-Dl-.Alpha.-Amino-N-Butyric Acid
6,8-Dichlorooctanamide
Trimethyl(3-Undecenyl)Silane
2,4-Di-Tert-Butylphenol
L-Prolinamide
Coumarin
Dl-Alanyl-Dl-Leucine
L-Proline
S-Carboxymethyl-L-Cysteine
.Alpha.,.Beta.-Gluco-Octonic Acid Lactone
L-Glutamic Acid
D-Xylulose
Tetradecane, 1,1'-Thiobis4,4-Dimethyl Octane
O-Acetyl-L-Serine
2,6-Dimethylcyclohexanone
L-Asparagine
D-(-)-Ribose
Undecane
2(3H)-Furanone, 3-BromodihydroHistidine
Alpha-Phenylbutyric Acid Trimethylsilyl Ester
Acetonyl Acetone
Adonitol
6-Phenylhexanoic Acid
Rac-Glycerol 3-Phosphoate
L-Tyrosine
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MQScore
0.91
0.96
0.96
0.95
0.93
0.95
0.84
0.99
0.90
0.81
0.81
0.88
0.82
0.88
0.91
0.96
0.85
0.81
0.99
0.98
0.91
0.87
0.85
0.85
0.82
0.95
0.93
0.81
0.89
0.96
0.82
0.90
0.84
0.91
0.88
0.89
0.87

Table B.1 (continued)
RT (min)
8.27
8.27
8.37
8.43
8.52
8.52
8.52
8.52
8.62
8.67
8.67
8.67
8.67
8.78
8.81
8.89
8.89
8.92
8.92
8.92
8.92
8.97
9.04
9.04
9.04
9.07
9.15
9.28
9.28
9.42
9.50
9.50
9.58
9.58

Library ID
Phenylhydrazine
Tert-Hexadecanethiol
2-Propanone, 1,1,1,3,3,3-HexafluoroL-Ornithine
1-Bromo-2-Methylpropane
Palmitic Acid
1-Monostearin
2(1H)-Pyrimidinone, 5-(4-Methylphenoxy)-4-(4Nitrophenyl)-6-PhenylD-Glucitol, 1,4:3,6-Dianhydro-2,5-Di-O-MethylD-(+)-Mannose
2-Bromo Dodecane
9-Undecylanthracene
2-Hydroxy-1,2,3-Propanetricarboxylic Acidtributyl
Ester
5-(P-Chlorophenyl)-3-(6-Methyl-3-Pyridyl)-1-(PTolyl)-2-Pyrazoline
3-Methyl-N-Octyl-2-Pyrrolidone
Methylmalonic Acid
5,5'-(Hexafluoroisopropylidene)Bis(O-Toluidine)
D-(+)-Glucose
Maltose
L-Ascorbic Acid
4-Amino-2-(P-Cumenyl)-7-Methoxy-5H(1)Benzopyrano(4,3-D)Pyrimidin-5-One
L-Iditol
Melezitose
Ureidosuccinic Acid
Mannitol
5-(P-Aminophenyl)-2-Thiazolamine
3-Ethoxycarbonylquinoxaline 1-Oxide
Alpha-Lactose
N-Acetylputrescinium
Oleic Acid
(-)-Shikimic Acid
Perfluoro(2-Methylpentane)
2-Methylpentadecanoic Acid Trimethylsilylester
(Z)-11-Hexadecenal
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MQScore
0.82
0.93
0.88
0.82
0.90
0.84
0.88
0.84
0.82
0.95
0.84
0.84
0.99
0.99
0.82
0.91
0.82
0.94
0.86
0.86
0.88
0.96
0.87
0.89
0.88
0.82
0.89
0.92
0.85
0.96
0.95
0.89
0.87
0.87

Table B.1 (continued)
RT (min)
9.58
9.58
9.58
9.66
9.66
9.75
9.75
9.84
9.84
9.84
9.84
9.93
9.99
9.99
9.99
10.12
10.12
10.16
10.16
10.26
10.34
10.34
10.4
10.47
10.47
10.53
10.53
10.53
10.60
10.68
10.76
10.76
10.76
10.86
10.86
10.86

Library ID
Myo-Inositol
2,3-Epoxypropyl Methacrylate
3-Methyl-1-Propyl-2-Pyrazoline
Hexadecane
Gamma-Amino-N-Butyric Acid
Propyl Acetate
Propanal, Di-2-Propenylhydrazone
Pentadecane
Tripropylamine
Methyl 2-Trimethylsiloxyoctadecanoate
Eicosane
Octanal, 7-Methoxy-3,7-DimethylPentanoic Acid
3-Methyltetrahydrofuran
4-Dimethylamino-2(5H)-Furanone
Bis(3-Methyl-2-Butenyl)(Tert-Butyl)Amine
1-Heptanol
Docosane
Propane, 2-Methoxy-2-Methyl3-Methyluracil
Isobutyramide, N-(2-Butyl)-N-Ethyl2(1H)-Pyrimidinethione, 4-AminoGlyoxylic Acid
Melibiose
Acetamide, 2,2,2-Trifluoro-N-Methyl-N(Trifluoroacetyl)Tetracosane
Indolelactic Acid
Hexanoylglycine
S,S'-Pentamethylene Bis(Benzenethiosulfonate)
Heptacosane
D-(+)-Trehalose
Dl-Threo-Beta-Methylaspartic Acid
Heneicosanoic Acid Trimethylsilyl Ester
Tetracosane
Decane, 1-IodoLuteolin
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MQScore
0.82
0.97
0.84
0.90
0.96
0.94
0.83
0.92
0.80
0.82
0.91
0.82
0.99
0.88
0.87
0.82
0.82
0.98
0.82
0.88
0.90
0.90
0.99
0.81
0.81
0.87
0.89
0.85
0.83
0.98
0.90
0.94
0.88
0.93
0.84
0.80

Table B.1 (continued)
RT (min)
10.93
10.93
10.93
10.99
11.08
11.17
11.17
11.22
11.22
11.22
11.28

Library ID
Nonacosane
Hexadecanoic Acid Trimethylsilyl Ester
2-Pentanone, 4-Methoxy-4-MethylHeptaethylene Glycol Monododecyl Ether
Ethyl 3-Hydroxyoctadecanoate
1,2-Diaminopropane
Benzene, 1-(Bromomethyl)-4-MethylEicosane
N-Acetyl-D-Glucosamine
Uridine 5'-Diphospho-N-Acetylglucosamine
3-(2-Isopropyl-5-Methylphenyl)-2-Methylpropionic
Acid
11.35
D-(-)-Fructose
11.35
M-Xylyl Bromide
11.41
Heptadecane
11.41
L-(+)-Ascorbic Acid 2,6-Dihexadecanoate
11.41
Trifluoromethanesulfonic Anhydride
11.41
Folpet (Fungicide)
11.47
3-Methoxy-3-Methylbutanol
11.47
(E)-3,7-Dimethyl-2,6-Octadienenitrile
11.55
Sucrose
11.55
(Z)-3,7-Dimethyl-2,6-Octadienenitrile
11.55
D-Fructose
11.55
Methsuximide
11.61
N-(4-Hydroxyphenylacetyl)Piperidin-2-One
11.72
Adenosine
11.82
N-Methyldodecanamide
11.82
(22R,25S)-22,26-Epimino-5Alpha-Cholestan-3BetaOl
11.93
3Alpha,4Alpha,5Beta-Tri(Trimethylsilyloxy)-1Cyclohexene-1-Carboxylic Acid Trimethylsilyl Ester
12.05
1-O-Tetradecylglycerol 2,3-Ditrimethylsilyl Ether
12.07
Pentacosane
12.07
2-Oxopentanoic Acid Trimethylsilyl Ester
12.07
Heptadecanoic Acid Trimethylsilyl Ester
12.14
3-Cresotinic Acid
12.14
1-Monopalmitin
Place MQscore: library match score
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MQScore
0.92
1.00
0.94
0.82
0.94
0.91
0.96
0.93
0.84
0.81
0.89
0.83
0.91
0.83
0.99
0.94
0.89
0.83
0.85
0.96
0.89
0.82
0.82
0.86
0.93
0.94
0.83
1.00
0.88
0.83
0.81
0.83
0.83
0.82

Table B.2

Results from the MetaboAnalyst pathway mapping

Column1
Aminoacyl-tRNA
biosynthesis
Alanine, aspartate and
glutamate metabolism
Arginine biosynthesis
Cyanoamino acid metabolism
Nitrogen metabolism
Arginine and proline
metabolism
Ubiquinone and other
terpenoid-quinone
biosynthesis
Glyoxylate and dicarboxylate
metabolism
Pentose phosphate pathway
Carbapenem biosynthesis
Glycine, serine and threonine
metabolism
Monobactam biosynthesis
Atrazine degradation
Methane metabolism
Amino sugar and nucleotide
sugar metabolism
Butanoate metabolism
Valine, leucine and isoleucine
degradation
Phenylalanine metabolism
Taurine and hypotaurine
metabolism
Valine, leucine and isoleucine
biosynthesis
Phenylalanine, tyrosine and
tryptophan biosynthesis
Purine metabolism
beta-Alanine metabolism
Pentose and glucuronate
interconversions
Sphingolipid metabolism
Sulfur metabolism

Total
46

Expected
3.9116

Hits
13

22

1.8707

7

18
8
5
25

1.5306
0.68027
0.42517
2.1259

6
3
2
4

2

0.17007

1

26

2.2109

4

18
3
32

1.5306
0.2551
2.7211

3
1
4

4
4
23
24

0.34014
0.34014
1.9558
2.0408

1
1
3
3

14
18

1.1905
1.5306

2
2

7
7

0.59524
0.59524

1
1

20

1.7007

2

21

1.7857

2

62
11
12

5.2721
0.93537
1.0204

5
1
1

13
13

1.1054
1.1054

1
1
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Table B.2 (continued)
Column1
Cysteine and methionine
metabolism
Fructose and mannose
metabolism
Glycerolipid metabolism
Tyrosine metabolism
Starch and sucrose
metabolism
Lysine biosynthesis
Histidine metabolism
Inositol phosphate metabolism
Pyruvate metabolism
Porphyrin and chlorophyll
metabolism
Glycolysis / Gluconeogenesis
Glutathione metabolism
Phosphatidylinositol signaling
system
Pyrimidine metabolism

B.2

Total
41

Expected
3.4864

Hits
3

14

1.1905

1

14
15
15

1.1905
1.2755
1.2755

1
1
1

16
18
22
23
23

1.3605
1.5306
1.8707
1.9558
1.9558

1
1
1
1
1

24
26
26

2.0408
2.2109
2.2109

1
1
1

34

2.8912

1

Non-volatile metabolites identified from the flat and fluffy solvent extraction

Table B.3
RT (min)
3.06
3.53
3.81
3.87
3.99
3.99
4.05
4.08
4.08
4.28
4.28
4.28
4.38
4.38

Non-volatile compounds identified from the MP flat vs fluffy analysis
Library ID
Disilane, HexamethylDisiloxane, Hexamethyl1,1-Dimethoxy-2,4-Dichloro-3-Methylenebutane
1,1,1-Trimethyldisilane
2-Pyridinecarboxylic Acid Methyl Ester
Acrylonitrile
Benzene
Acetic Acid, ChloroPyridine
2-Chloropropane (1,1,1,2,3,3,3-D7)
Aniline
Bis(Chloromethyl) Ether
2,4-Dinitroaniline
Bromobenzene
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MQScore
0.90
0.97
0.98
1.00
0.97
0.85
0.81
0.84
0.83
0.88
0.81
0.98
0.83
0.89

p-value
3.126E-05
3.330E-07
2.641E-04
1.065E-05
3.601E-03
2.659E-05
9.361E-02
7.548E-03
3.601E-03
1.965E-03
1.579E-02
2.233E-02
2.250E-07
4.084E-02

Table B.3 (continued)
RT (min)
4.38
4.46
4.46
4.49
4.63
4.66
4.71
4.75
4.79
4.88
4.93
5.04
5.07
5.10
5.14
5.17
5.21
5.36
5.44
5.44
5.66
5.66
5.80
5.90
6.08
6.08
6.27
6.27
6.37
6.58
6.58
6.58
6.75
6.75
7.02
7.47
7.47
7.60
7.60
7.69
7.72

Library ID
8Fiehn Vocbinbase Bin #845
1-Propyne, 3-Chloro2-Pyridinecarboxaldehyde
4-Pyridinecarboxylic Acid Methyl Ester
(Methylbenzene)Tricarbonylchromium
Propane, 1,1,3,3-Tetramethoxy2-Propenoic Acid, 3-Phenyl-, Phenyl Ester, (E)Tert-Butyldimethylsiloxybutane
Benzene, (2,2-Dimethoxyethoxy)Carbonic Acid, Allyl 3,5-Difluophenyl Ester
Dimethylsulfoxonium Formylmethylide
L-Norleucine
Ethanol, 2-(Trimethylsilyl)2-Dibenzofuranol
8Fiehn Vocbinbase Bin #867
Ethyleneglycol Dimethyl Ether
S-[4-Cyanophenyl]-N,N-Dimethylthiocarbamate
Chloropentamethyldisilane
1,3-Diphenyl-2-(Methylamino)Propanol
Hexamethyldisilane
L-Valine
Ortho-Hydroxyphenylacetic Acid
1,1,1,2-Tetramethyldisilane (2,2-D)
Benzenemethanamine, N,N,.Alpha.-TrimethylBenzaldehyde
Methoxycitronellal
M-Cresyl Acetate
Tetracosylamine, N,N-DimethylAcetamide, 2,2,2-Trifluoro-N-Methyl4-Methylcatechol
8Fiehn Vocbinbase Bin #1112
8Fiehn Vocbinbase Bin #968
1,1,1,2-Tetramethyldisilane
1,2-Dimethyl-1,2-Dipropyldisilane
D-(+)-Malic Acid
6-Methyl-4-Trimethylsilylmethyl-5,6-Dihydro-2HPyran
Tetraethylene
Glycol
2-Thiazolidinethione
8 Pentadecane
Triethylene Glycol
2-Oxobicyclo(3.2.2)Nona-3,6-Dien-1-Yl Benzoate
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MQScore
0.82
0.84
0.82
0.92
0.89
0.89
0.81
0.82
0.85
0.89
0.85
0.96
0.83
0.83
0.86
0.96
0.80
0.87
0.80
0.85
0.83
0.82
0.98
0.80
0.88
0.90
0.84
0.97
0.87
0.99
0.89
0.84
0.82
0.97
0.85
0.83
0.85
0.91
0.89
0.96
0.85

p-value
1.586E-04
5.400E-03
4.292E-03
2.834E-02
2.026E-02
2.343E-02
1.838E-04
8.328E-02
1.427E-02
8.887E-03
6.814E-02
1.838E-04
5.773E-02
2.365E-03
7.548E-03
1.661E-02
1.269E-04
1.835E-02
5.400E-03
8.662E-02
3.394E-03
1.735E-03
6.814E-02
9.361E-02
9.894E-03
1.929E-02
3.013E-03
4.660E-02
4.867E-02
7.693E-02
1.109E-03
1.501E-02
1.355E-02
1.835E-02
2.671E-03
7.693E-02
5.714E-03
4.548E-03
9.006E-02
1.039E-03
3.111E-02

Table B.3 (continued)
RT (min)
7.72
7.81
7.89
7.89
7.95
7.97
8.10
8.26
8.26
8.55
8.65
8.71
8.85
8.85
9.02
9.02
9.05
9.26
9.46
9.70
9.73
9.78
9.78
9.88
9.88
9.88
9.98
9.98
9.98
10.04
10.14
10.14
10.14
10.20
10.30
10.37
10.37
10.61
10.72
10.79
10.79

Library ID
Dl-Beta-Hydroxybutyric Acid
Lactic Acid
3-Nitrophthalic Acid Bis (Trimethylsilyl) Ester
Oxalate
Trans-Cinnamic Acid
1,2,3-Trimethoxy-4-Phenylbutane
2,2-Dimethyl-1-Trimethylsilyl-2-Silaindoline
2-Phenylpropanal Ethylene Glycol Acetal
Triethylene Glycol Monomethyl Ether
Glycolic Acid
Butanoic Acid, 2-Amino-4-(Methylsulfinyl)-, (.+/-.)8Fiehn Vocbinbase Bin #540
3-Methoxy-3-Methylbutanol
N-Octadecane
Benzo(B)Thiophene-3-Acetamide
Tert-Butyldimethylsilanol
Silanol, Trimethyl-, Phosphate (3:1)
8Fiehn Vocbinbase Bin #1292
D-Ribose 5-Phosphate
Glycylglycine
Cyclohexanecarboxylic Acid Trimethylsilylester
Methyl Octadecanoate
N(2),N(2)-Dimethyl-1,2-Butanediamine
2-Methoxyethanol
8Fiehn Vocbinbase Bin #35
8Fiehn Vocbinbase Bin #524
2-Trimethylsiloxyoctane
N-Acetyl-Valyl-Leucyl-Glycine Methylester
8 Pentanone (2-)
3-Methylglutaric Acid Di-Tms
1-Ethyl-1-Isobutylhydrazine
5-Benzyloxypyrimidine-2-Carboxylic Acid
N-Tert-Butylphthalimide
Bis(Trimethylsilyl)Trifluoroacetamide
Sarcosine
1-Octanamine, N-Methyl-N-OctylL-(-)-Threonine
2-Oxopentanoic Acid Trimethylsilyl Ester
D-Alanine
N-Methyl-Dl-Alanine
8Fiehn Vocbinbase Bin #497
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MQScore
0.97
0.98
0.97
0.88
0.97
0.85
0.88
0.99
0.84
0.86
0.82
0.83
0.89
0.98
0.90
0.82
0.86
0.89
0.83
0.95
1.00
0.98
0.85
0.96
1.00
0.97
0.98
0.89
0.89
0.89
0.98
0.82
0.83
0.96
0.84
0.99
1.00
0.80
0.83
0.98
0.99

p-value
7.097E-02
2.343E-02
1.346E-03
4.049E-03
1.835E-02
4.269E-02
1.622E-05
2.837E-04
8.005E-02
6.814E-02
1.978E-04
7.390E-02
4.867E-02
1.287E-02
2.837E-03
9.379E-03
7.097E-02
3.111E-02
8.328E-02
3.410E-02
1.355E-02
3.672E-05
2.969E-02
6.814E-02
7.693E-02
5.468E-08
2.641E-04
7.390E-02
1.177E-04
1.346E-03
1.039E-03
3.394E-03
2.091E-03
1.517E-06
5.304E-02
6.020E-02
8.005E-02
5.081E-02
7.693E-02
1.735E-03
9.727E-02

Table B.3 (continued)
RT (min)
10.92
10.92
11.32
11.45
11.51
11.51
11.65
11.77
11.83
11.85
11.85
12.04
12.24
12.24
12.39
12.39
12.51
12.51
12.58
12.72
12.72
12.72
12.79
12.87
13.14
13.14
13.21
13.29
13.39
13.39
13.39
13.50
13.50
13.50
13.58
13.58
13.65
13.65
13.76
13.76
13.91

Library ID
Methylmalonic Acid
Methylpentylsilane
L-Aspartic Acid
2-Butoxy-N-(2-(Diethylamino)Ethyl)-4Quinolinecarboxamide
2-Methylaminomethyl-1,3-Dioxolane
8Fiehn Vocbinbase Bin #114
L-Tyrosine
3-Trimethylsilylmethyl-4-Hydroxy-2-Methyl-1Hexene
Dl-Alanyl-Dl-Leucine
Dl-Alanyl-Dl-Methionine
Methyl 5-Methylthio-3-Oxopentanoate
Ethyl 1,2-Dihydro-6-Methoxy-2-Oxoquinoline-4Carboxylate
1,2-Benzenediol,
3-Fluoro2,2-Dimethyl-1-Oxa-2-Silacyclohexanone-6
.Alpha.,.Beta.-Gluco-Octonic Acid Lactone
1,3-Bis(Dimethylsilyl)Propane
Bromodiphenhydramine
8 Heptacosane
D-(-)-Ribose
Hexanoylglycine
Methyl Tetradecanoate
N,N-Dipropylnitrosoamine
Cephaloridine
Rac-Glycerol 3-Phosphoate
Dl-Threo-Beta-Methylaspartic Acid
Methyl 2-Trimethylsiloxy-Hexadecanoate
Citric Acid
L-Arginine
Cyclohexane
Monomethyl Glutaric Acid
Pent-4-Enoylamide, 2,N-Dimethyl-N-Isobutyl5-Methyl-1,3-Cyclohexanedione
Pentacosane
8 Eicosane
D-(+)-Galactose
8 Docosane
Ethyl Lactate
8Fiehn Vocbinbase Bin #920
L-Ascorbic Acid
Talose
Melezitose
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MQScore
1.00
0.84
0.86
0.82
0.80
0.97
0.84
0.88
1.00
0.90
0.80
0.82
0.84
0.85
0.96
0.83
0.81
0.92
0.89
0.90
0.99
0.98
0.84
0.92
0.84
0.85
0.83
0.85
0.81
0.99
0.83
0.84
0.88
0.88
0.88
0.95
0.93
0.84
0.86
0.92
0.92

p-value
4.084E-02
5.700E-04
1.746E-02
3.410E-02
2.659E-05
1.044E-02
5.400E-03
2.641E-04
2.641E-04
2.739E-07
7.693E-02
5.773E-02
2.704E-02
1.287E-02
4.639E-04
5.398E-07
6.533E-07
1.492E-05
1.044E-02
2.622E-06
2.367E-08
1.261E-06
1.629E-03
1.435E-03
7.468E-04
6.275E-02
1.929E-02
2.514E-03
9.380E-05
8.048E-05
2.365E-03
1.346E-09
4.461E-02
2.883E-05
9.380E-05
8.662E-02
6.529E-04
3.389E-05
1.473E-04
3.569E-02
8.677E-07

Table B.3 (continued)
RT (min)
13.99
14.16
14.26
14.55
14.73
14.73
14.73
14.76
14.81
14.81
14.92
15.10
15.16
15.23
15.41
15.55
15.68
15.68
15.71
15.71
15.87
15.96
16.03
16.12
16.24
16.43
16.67
16.74
16.82
17.04
17.29
17.29
17.29
17.46
17.69
17.69
17.86
17.86
17.98
18.17
18.20

Library ID
Mannitol
D-(+)-Trehalose
Alpha-Lactose
Myo-Inositol
2-Naphthaleneacetic Acid Trimethylsilyl Ester
D-Mannonic Acid, .Gamma.-Lactone
Linoleic Acid
8Fiehn Vocbinbase Bin #491
8Fiehn Vocbinbase Bin #1199
8Fiehn Vocbinbase Bin #1428
8Fiehn Vocbinbase Bin #297
8Fiehn Vocbinbase Bin #241
2-Octanoylthiophene
L-Homoserine
2,3-Dihydroxy-3,7,11,15-Tetramethylhexadecan-1-Ol
Nitrate Vocbinbase Bin #1225
8Fiehn
10-Pentadecenal
8Fiehn Vocbinbase Bin #451
N-Methyldodecanamide
Oleic Acid
8Fiehn Vocbinbase Bin #1400
Propargyl Chloride
1,1,2,2,3,3-Hexamethyltrisilane (D2)
Acetylphosphate
Thiourea
Methyl Orotate
8Fiehn Vocbinbase Bin #1354
8Fiehn Vocbinbase Bin #1337
8Fiehn Vocbinbase Bin #1269
6-Methyl-3-(Trimethylsilyl)Methyl-1-Hepten-4-Ol
3-Methyl-1-Propyl-2-Pyrazoline
Dl-P-Chlorophenylalaninol
Fumaric Acid, Di(3-Methylbut-3-Enyl) Ester
Inosine
2'-Deoxyadenosine
Benzene, 1-Methyl-3-(1-Methylethyl)2,2'-Dimethyl-Alpha,Alpha'-Bis(O-Toluoyloxy)Trans-Stilbene
8Fiehn
Vocbinbase Bin #1411
1H-Purine, 2-Methyl2-[2-[2-Methoxyethoxy]Ethoxy-1,3-Dioxalane
3-Indoleacetic Acid-Di-Tms
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MQScore
0.94
0.94
0.90
0.88
0.83
0.84
0.82
0.89
0.84
0.81
0.88
0.97
0.82
0.96
1.00
0.97
0.93
0.85
0.91
0.90
0.96
0.88
0.99
0.98
0.97
0.88
0.84
0.81
0.80
0.96
0.89
0.81
0.89
0.96
0.85
1.00
0.98
0.84
0.90
0.84
0.88

p-value
4.307E-05
1.177E-04
2.224E-03
3.111E-02
6.480E-09
3.047E-04
2.459E-02
2.450E-05
2.834E-02
2.080E-05
4.044E-07
6.020E-02
8.419E-03
3.734E-02
2.671E-03
1.664E-06
1.509E-09
3.330E-07
2.026E-02
1.746E-02
7.693E-02
9.115E-04
6.275E-02
5.400E-03
1.661E-02
1.763E-05
3.601E-03
1.261E-06
7.144E-03
8.005E-02
5.773E-02
4.454E-07
5.304E-02
7.097E-02
5.534E-02
2.704E-02
1.261E-05
4.652E-09
4.100E-06
5.400E-03
2.579E-02

Table B.3 (continued)
RT (min) Library ID
MQScore p-value
18.26
1-Isobutyl-3-Methyl-2-Pyrazoline
0.90
2.459E-02
18.26
2,4,4-Trimethyl-1-Pentene
0.99
4.461E-02
18.38
8Fiehn Vocbinbase Bin #925
0.89
5.400E-03
18.48
3,6-Dimethyl-1-Heptyn-3-Ol
0.88
4.444E-08
18.48
8Fiehn Vocbinbase Bin #1460
0.91
8.005E-02
18.64
Benzene, 1,1'-(1,3-Butadiyne-1,4-Diyl)Bis0.84
1.691E-09
18.66
Methylthiomethyl P-Tolyl Sulfone
0.84
3.257E-02
18.70
Hexestrol
0.88
7.144E-03
18.76
2,4-Pentanedione, 1,1,1,5,5,5-Hexafluoro0.89
1.427E-02
18.79
Acetamide, 2,2,2-Trifluoro-N-Methyl-N0.93
2.704E-02
18.87
8(Trifluoroacetyl)Decane
0.98
9.379E-03
MQScore is the library match score , Fiehn Vocbinbase Bin #number is the compound id match
to the Fiehn voc database, and that name with # tag was the IDs of the Fiehn database.
P-value obtained from the Mann Whitney-U test
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B.3

VOCs associated with the MP Flat and Fluffy

Table B.4
RT
(min)
4.37
5.60
5.87
6.51
6.99
7.74
7.74
8.08
8.64
8.74
8.93
9.33
9.42
9.79
9.96
9.96
10.02
10.02
10.43
10.51
10.76
10.88
10.96
10.96
11.06

Volatile compounds identified from the MP flat vs fluffy analysis
Library ID
2-Propanamine
"L-Alanine Ethylamide, (S)-"
3-Cresotinic Acid
Methoxy Acetic Acid
Ethyl Acetate
1-Butanol
Guanidine
Toluene
2-Propanol
"N,N,O-Triacetylhydroxylamine"
Fiehn Vocbinbase Bin #124
"1,3-Cycloheptadiene"
Dimethyl Disulfide
Isobutyl Acetate
Acetylacetone
Tridecane
Octanol (2-)
Fiehn Vocbinbase Bin #854
Nonen-1-Al (2E-)
Heptanol (2-)
Fiehn Vocbinbase Bin #509
Fiehn Vocbinbase Bin #1375
"3-Hexen-2-One, 5-Methyl-"
Glycolic Acid
5-Oxohexanenitrile

MQScore
0.93
0.89
0.95
0.83
0.86
0.90
0.92
0.86
0.89
0.93
0.73
0.72
0.94
0.83
0.80
0.68
0.72
0.78
0.74
0.85
0.81
0.87
0.85
0.94
0.91
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p-value
6.9E-05
1.0E-04
2.0E-04
2.4E-04
3.7E-04
1.1E-03
1.2E-03
1.6E-03
2.1E-03
2.4E-03
2.6E-03
3.0E-03
3.1E-03
3.2E-03
3.6E-03
3.9E-03
4.0E-03
4.1E-03
4.6E-03
4.7E-03
5.4E-03
5.8E-03
6.0E-03
6.8E-03
7.7E-03

Table B.4 (continued)
RT
(min)
11.17
11.17
11.26
11.43
11.68
11.78
11.84
11.84
11.93
12.00
12.00
12.88
13.04
13.15
13.38
13.69
13.69
13.75
14.02
14.12
14.31
14.43
14.43
14.62
14.74
14.80
15.03
15.27
15.36
15.54

Library ID
"2-Cyclopenten-1-One, 2,3Dimethyl-"
Fiehn Vocbinbase Bin #527
"Thiophene, Tetrahydro-2Methyl-"
"2,4-Dimethyl-1-Heptene"
"1-Butanol, 3-Methyl-, Acetate"
Fiehn Vocbinbase Bin #1526
"Phenol, 2-Methyl-5-(1Methylethyl)-"
5-Nonanone
Fiehn Vocbinbase Bin #1046
"2-Propene-1,1-Diol, Diacetate"
Dl-Alanyl-Dl-Methionine
Fiehn Vocbinbase Bin #363
1-Nonyne
Tetradecene (1-)
Benzaldehyde
Methyl Lactate
Hepten-2-One (6-Methyl-5-)
Fiehn Vocbinbase Bin #545
Fiehn Vocbinbase Bin #476
"Pyrazine, Trimethyl-"
Pinene (Alpha-)
"Nonane, 2,2,4,4,6,8,8Heptamethyl-"
Geraniol
Ethylhexanol
1,4-Cineole
Hydroxybutanoic Acid Lactone
(4-)
Fiehn Vocbinbase Bin #1192
Cresol (Meta-)
N-Octadecane
Dihydromyrcenol

MQScore p-value
0.90
0.80

8.2E-03
9.1E-03

0.88
0.83

9.3E-03
9.3E-03

0.88
0.87

9.6E-03
1.0E-02

0.77
0.91
0.96
0.95
0.82
0.88
0.91
0.87
0.80
0.73
0.83
0.71
0.94
0.83
0.71

1.1E-02
1.1E-02
1.1E-02
1.2E-02
1.2E-02
1.2E-02
1.3E-02
1.4E-02
1.5E-02
1.8E-02
1.8E-02
1.9E-02
2.1E-02
2.2E-02
2.3E-02

0.67
0.92
0.94
0.85

2.3E-02
2.4E-02
2.5E-02
2.5E-02

0.78
0.85
0.90
0.85
0.67

2.6E-02
2.7E-02
2.7E-02
2.8E-02
3.0E-02
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Table B.4 (continued)
RT
(min)
15.77
15.87
15.90
16.02
16.02
16.02
16.14
16.22
16.28
16.28
16.47
16.47
17.33
17.49
17.54
17.54
17.64
17.64
17.72
18.25
18.42
18.56
18.56
18.78
18.88
18.97
19.16
19.21
19.40
19.40
19.46
19.46
19.74

Library ID
"Pentane, 2,2,3,4-Tetramethyl-"
"Phenol, 2-Methoxy-"
Fiehn Vocbinbase Bin #208
2-Methoxyethanol
4-Pentyn-2-Ol
Monomethyl Glutaric Acid
Linalool
Oxalic Acid
2-Isobutyl-3-Methylpyrazine
Fiehn Vocbinbase Bin #1359
"2(3H)-Furanone, 3Bromodihydro-"
Pentanone (2-)
Fiehn Vocbinbase Bin #30
Dodecanol
"2-Pyrrolidinone, Tms
Derivative"
Fiehn Vocbinbase Bin #1017
Benzoic Acid
P-Tolylacetic Acid
Fiehn Vocbinbase Bin #393
Fiehn Vocbinbase Bin #1340
Sabinene Hydrate Acetate (Cis-)
Camphene
Naphthalene
Citronellol
Tartaric Acid-Tetra-Tms
Fiehn Vocbinbase Bin #276
Fiehn Vocbinbase Bin #391
Fiehn Vocbinbase Bin #1449
Phenylethyl Acetate
Phenylacetaldehyde
"2,5-Dimethylcyclohexanol"
Propyl Acetate
"Butane, 1,1'-Oxybis[4-Chloro-"

MQScore
0.88
0.85
0.97
0.87
0.68
0.83
0.93
0.76
0.89

p-value
3.1E-02
3.4E-02
3.8E-02
3.8E-02
3.9E-02
4.0E-02
4.0E-02
4.0E-02
4.1E-02

0.90

4.1E-02

0.88
0.87
0.81
0.94

4.2E-02
4.5E-02
4.5E-02
4.6E-02

0.82
0.84
0.83
0.79
0.94
0.86
0.79
0.68
0.92
0.83
0.88
0.79
0.76
0.97
0.88
0.78
0.82
0.81
0.85
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5.1E-02
5.4E-02
5.4E-02
5.6E-02
5.8E-02
5.8E-02
5.9E-02
5.9E-02
6.5E-02
6.5E-02
6.5E-02
6.5E-02
7.0E-02
7.1E-02
7.1E-02
7.3E-02
7.3E-02
7.3E-02
7.8E-02

Table B.4 (continued)
RT
(min)
19.74
19.80

Library ID
MQScore p-value
Citral
0.73
7.8E-02
"Benzene, 1-Propenyl-"
0.75
8.0E-02
"Octanal, 7-Methoxy-3,719.91
Dimethyl-"
0.82
8.2E-02
1,3-Di-Tert-Butylbenzene
19.91
0.93
8.2E-02
Octane
20.07
0.89
8.3E-02
Fiehn Vocbinbase Bin #662
20.07
0.89
8.5E-02
"2,7-Octadien-1-Ol"
20.17
0.72
8.5E-02
2-Tridecanone
20.29
0.91
8.7E-02
2-Hexanol
20.55
0.94
8.7E-02
2-Methyl Imidazoline
20.90
0.88
8.9E-02
Fiehn Vocbinbase Bin #1409
21.48
0.85
9.1E-02
Undecanol (N-)
21.58
0.93
9.5E-02
MQScore is the library match score, and Fiehn Vocbinbase Bin #number is the compound id
match to the Fiehn VOC database, and that name with # tag was the IDs of the Fiehn database.
P-value obtained from the Mann Whitney-U test.

Table B.5

The result of the MP flat and fluffy pathway analysis at MetaboAnalyst

Pathway
Valine, leucine and isoleucine
degradation
Biosynthesis of unsaturated fatty acids
Starch and sucrose metabolism
Galactose metabolism
Valine, leucine and isoleucine
biosynthesis
Pantothenate and CoA biosynthesis
Amino sugar and nucleotide sugar
metabolism
Glycolysis / Gluconeogenesis
Aminoacyl-tRNA biosynthesis

Total

Expected Hits

18
23
15
17

0.44898
0.57370
0.37415
0.42404

2
2
1
1

20
20

0.49887
0.49887

1
1

24
24
46

0.59864
0.59864
1.14740

1
1
1
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APPENDIX C
SUPPLEMENTARY MATERIAL FOR OPTIMIZED UNTARGETED METABOLOMICS
APPROACH FOR THE ANALYSIS OF MYCORRHIZAE FUNGI USING GC-MS
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C.1

AM harvesting

AM hyphae

Figure A.1

Hyphae fast extraction

Extracted Am hyphae on a 38 um sieve and confirmation of the AM root colonization

Figure A.2

Light microscope image of stained soybean root section (40X)
173

C.2

PLS-DA analysis of the salinity stressed and non-stressed hyphae

Figure A.3

PLS-DA score plot of hyphae stressed and non-stressed groups, B: Model
performance by ten-fold cross-validation R2 = 0.9, Q2 = 0.16, C: PLS-DA 1000
times permutation test.

Q2 and R2 of the PLS-DA analysis were used to express the reliability of the predictive model.
Q2 estimates the predictive ability of the PLS-DA.
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